TW202116781A - 新穎雜環化合物 - Google Patents
新穎雜環化合物 Download PDFInfo
- Publication number
- TW202116781A TW202116781A TW109123050A TW109123050A TW202116781A TW 202116781 A TW202116781 A TW 202116781A TW 109123050 A TW109123050 A TW 109123050A TW 109123050 A TW109123050 A TW 109123050A TW 202116781 A TW202116781 A TW 202116781A
- Authority
- TW
- Taiwan
- Prior art keywords
- chloro
- compound
- formula
- group
- phenyl
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 279
- 238000000034 method Methods 0.000 claims abstract description 170
- -1 cyano, hydroxyl Chemical group 0.000 claims description 206
- 150000003839 salts Chemical class 0.000 claims description 109
- 229910052739 hydrogen Inorganic materials 0.000 claims description 96
- 239000001257 hydrogen Substances 0.000 claims description 96
- 229910052736 halogen Inorganic materials 0.000 claims description 84
- 125000001072 heteroaryl group Chemical group 0.000 claims description 83
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 81
- 150000002367 halogens Chemical class 0.000 claims description 80
- 238000006243 chemical reaction Methods 0.000 claims description 61
- 150000002431 hydrogen Chemical class 0.000 claims description 56
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 50
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims description 48
- 241000124008 Mammalia Species 0.000 claims description 46
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 44
- 125000003118 aryl group Chemical group 0.000 claims description 42
- 125000005915 C6-C14 aryl group Chemical group 0.000 claims description 40
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 40
- 208000002193 Pain Diseases 0.000 claims description 39
- 125000001424 substituent group Chemical group 0.000 claims description 37
- 238000002360 preparation method Methods 0.000 claims description 32
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 30
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 29
- 230000002265 prevention Effects 0.000 claims description 29
- 230000036407 pain Effects 0.000 claims description 26
- 239000002585 base Substances 0.000 claims description 25
- 125000000623 heterocyclic group Chemical group 0.000 claims description 25
- 230000004770 neurodegeneration Effects 0.000 claims description 24
- GBXQPDCOMJJCMJ-UHFFFAOYSA-M trimethyl-[6-(trimethylazaniumyl)hexyl]azanium;bromide Chemical compound [Br-].C[N+](C)(C)CCCCCC[N+](C)(C)C GBXQPDCOMJJCMJ-UHFFFAOYSA-M 0.000 claims description 24
- 101150003085 Pdcl gene Proteins 0.000 claims description 23
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 23
- 208000015122 neurodegenerative disease Diseases 0.000 claims description 22
- 201000006417 multiple sclerosis Diseases 0.000 claims description 21
- PAQZWJGSJMLPMG-UHFFFAOYSA-N propylphosphonic anhydride Substances CCCP1(=O)OP(=O)(CCC)OP(=O)(CCC)O1 PAQZWJGSJMLPMG-UHFFFAOYSA-N 0.000 claims description 21
- 125000005843 halogen group Chemical group 0.000 claims description 20
- 125000001153 fluoro group Chemical group F* 0.000 claims description 19
- 208000024827 Alzheimer disease Diseases 0.000 claims description 17
- 239000007821 HATU Substances 0.000 claims description 17
- 206010028980 Neoplasm Diseases 0.000 claims description 17
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Substances CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 claims description 16
- CXNIUSPIQKWYAI-UHFFFAOYSA-N xantphos Chemical compound C=12OC3=C(P(C=4C=CC=CC=4)C=4C=CC=CC=4)C=CC=C3C(C)(C)C2=CC=CC=1P(C=1C=CC=CC=1)C1=CC=CC=C1 CXNIUSPIQKWYAI-UHFFFAOYSA-N 0.000 claims description 16
- 208000018737 Parkinson disease Diseases 0.000 claims description 15
- 201000011510 cancer Diseases 0.000 claims description 15
- 239000003153 chemical reaction reagent Substances 0.000 claims description 15
- 208000020016 psychiatric disease Diseases 0.000 claims description 15
- 208000030886 Traumatic Brain injury Diseases 0.000 claims description 14
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 13
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 13
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 13
- 230000009529 traumatic brain injury Effects 0.000 claims description 13
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 claims description 12
- 206010029240 Neuritis Diseases 0.000 claims description 12
- 206010029350 Neurotoxicity Diseases 0.000 claims description 12
- 206010044221 Toxic encephalopathy Diseases 0.000 claims description 12
- 230000007135 neurotoxicity Effects 0.000 claims description 12
- 231100000228 neurotoxicity Toxicity 0.000 claims description 12
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims description 12
- OZMLUMPWPFZWTP-UHFFFAOYSA-N 2-(tributyl-$l^{5}-phosphanylidene)acetonitrile Chemical compound CCCCP(CCCC)(CCCC)=CC#N OZMLUMPWPFZWTP-UHFFFAOYSA-N 0.000 claims description 11
- 150000002009 diols Chemical class 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 11
- 125000004076 pyridyl group Chemical group 0.000 claims description 11
- 208000019901 Anxiety disease Diseases 0.000 claims description 10
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 10
- 230000036506 anxiety Effects 0.000 claims description 10
- 239000003054 catalyst Substances 0.000 claims description 10
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 10
- 208000019695 Migraine disease Diseases 0.000 claims description 9
- 208000036110 Neuroinflammatory disease Diseases 0.000 claims description 9
- 208000006011 Stroke Diseases 0.000 claims description 9
- 238000006161 Suzuki-Miyaura coupling reaction Methods 0.000 claims description 9
- 238000002512 chemotherapy Methods 0.000 claims description 9
- 201000010099 disease Diseases 0.000 claims description 9
- 206010015037 epilepsy Diseases 0.000 claims description 9
- 206010027599 migraine Diseases 0.000 claims description 9
- 208000004296 neuralgia Diseases 0.000 claims description 9
- 230000003959 neuroinflammation Effects 0.000 claims description 9
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 8
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 8
- 125000002883 imidazolyl group Chemical group 0.000 claims description 8
- 201000001119 neuropathy Diseases 0.000 claims description 8
- 230000007823 neuropathy Effects 0.000 claims description 8
- 208000033808 peripheral neuropathy Diseases 0.000 claims description 8
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 7
- 208000000094 Chronic Pain Diseases 0.000 claims description 7
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 claims description 7
- 206010033128 Ovarian cancer Diseases 0.000 claims description 7
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 7
- 125000000304 alkynyl group Chemical group 0.000 claims description 7
- 150000001412 amines Chemical class 0.000 claims description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052794 bromium Inorganic materials 0.000 claims description 7
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims description 7
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims description 7
- 231100000844 hepatocellular carcinoma Toxicity 0.000 claims description 7
- 206010009944 Colon cancer Diseases 0.000 claims description 6
- 208000007101 Muscle Cramp Diseases 0.000 claims description 6
- 208000005298 acute pain Diseases 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims description 6
- 208000029742 colonic neoplasm Diseases 0.000 claims description 6
- 238000006880 cross-coupling reaction Methods 0.000 claims description 6
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 claims description 6
- 150000007529 inorganic bases Chemical class 0.000 claims description 6
- 150000007530 organic bases Chemical class 0.000 claims description 6
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 6
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 6
- 238000006467 substitution reaction Methods 0.000 claims description 6
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims description 6
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical group OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 5
- 229910052717 sulfur Inorganic materials 0.000 claims description 5
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 4
- 101100226004 Rattus norvegicus Erc2 gene Proteins 0.000 claims description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 4
- 239000012025 fluorinating agent Substances 0.000 claims description 4
- 230000000269 nucleophilic effect Effects 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 239000011593 sulfur Substances 0.000 claims description 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 3
- 238000003477 Sonogashira cross-coupling reaction Methods 0.000 claims description 3
- 239000013543 active substance Substances 0.000 claims description 3
- 230000008878 coupling Effects 0.000 claims description 3
- 238000010168 coupling process Methods 0.000 claims description 3
- 238000005859 coupling reaction Methods 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 201000010901 lateral sclerosis Diseases 0.000 claims description 3
- 208000005264 motor neuron disease Diseases 0.000 claims description 3
- 239000007800 oxidant agent Substances 0.000 claims description 3
- 229910052723 transition metal Inorganic materials 0.000 claims description 3
- 150000003624 transition metals Chemical class 0.000 claims description 3
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 claims description 2
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 claims description 2
- 102000005398 Monoacylglycerol Lipase Human genes 0.000 claims description 2
- 108020002334 Monoacylglycerol lipase Proteins 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims description 2
- 229940125797 compound 12 Drugs 0.000 claims description 2
- 230000018044 dehydration Effects 0.000 claims description 2
- 238000006297 dehydration reaction Methods 0.000 claims description 2
- 229940043279 diisopropylamine Drugs 0.000 claims description 2
- 230000001590 oxidative effect Effects 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 210000003205 muscle Anatomy 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 104
- 230000008569 process Effects 0.000 abstract description 21
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 239000000543 intermediate Substances 0.000 description 326
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 276
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 204
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 181
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 174
- 239000000047 product Substances 0.000 description 138
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 137
- 235000019439 ethyl acetate Nutrition 0.000 description 134
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 114
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 110
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 98
- 239000007787 solid Substances 0.000 description 88
- 239000000243 solution Substances 0.000 description 83
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 80
- 239000000377 silicon dioxide Substances 0.000 description 75
- 239000007858 starting material Substances 0.000 description 74
- 238000004440 column chromatography Methods 0.000 description 70
- 238000004128 high performance liquid chromatography Methods 0.000 description 61
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 60
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 58
- WSFSSNUMVMOOMR-BJUDXGSMSA-N methanone Chemical compound O=[11CH2] WSFSSNUMVMOOMR-BJUDXGSMSA-N 0.000 description 56
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 54
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 50
- 229910052786 argon Inorganic materials 0.000 description 49
- 238000003818 flash chromatography Methods 0.000 description 46
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 45
- 239000003921 oil Substances 0.000 description 45
- 235000019198 oils Nutrition 0.000 description 45
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 44
- 239000011541 reaction mixture Substances 0.000 description 43
- 239000011734 sodium Substances 0.000 description 43
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 40
- 239000012267 brine Substances 0.000 description 39
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 37
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 36
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 34
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 34
- 229910052938 sodium sulfate Inorganic materials 0.000 description 34
- 235000011152 sodium sulphate Nutrition 0.000 description 34
- 239000012043 crude product Substances 0.000 description 33
- 238000000746 purification Methods 0.000 description 33
- 239000002904 solvent Substances 0.000 description 33
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 32
- 229910004298 SiO 2 Inorganic materials 0.000 description 30
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 29
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 26
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 25
- 238000004808 supercritical fluid chromatography Methods 0.000 description 24
- 239000012074 organic phase Substances 0.000 description 23
- 229920006395 saturated elastomer Polymers 0.000 description 23
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 22
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 22
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 22
- 238000002953 preparative HPLC Methods 0.000 description 22
- 150000003335 secondary amines Chemical class 0.000 description 22
- 229940050390 benzoate Drugs 0.000 description 21
- 239000012044 organic layer Substances 0.000 description 20
- 125000006239 protecting group Chemical group 0.000 description 20
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 20
- 239000007864 aqueous solution Substances 0.000 description 18
- 239000000741 silica gel Substances 0.000 description 18
- 229910002027 silica gel Inorganic materials 0.000 description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 17
- 125000004432 carbon atom Chemical group C* 0.000 description 17
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 16
- 239000000460 chlorine Substances 0.000 description 16
- 239000012230 colorless oil Substances 0.000 description 16
- 235000021342 arachidonic acid Nutrition 0.000 description 15
- 239000013058 crude material Substances 0.000 description 15
- 229940095102 methyl benzoate Drugs 0.000 description 15
- 229940114079 arachidonic acid Drugs 0.000 description 14
- 238000005160 1H NMR spectroscopy Methods 0.000 description 13
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 12
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 11
- OWPJVOSLLKRKQJ-UHFFFAOYSA-N methyl 3-bromo-2-chlorobenzoate Chemical compound COC(=O)C1=CC=CC(Br)=C1Cl OWPJVOSLLKRKQJ-UHFFFAOYSA-N 0.000 description 11
- 229910000027 potassium carbonate Inorganic materials 0.000 description 11
- 235000011181 potassium carbonates Nutrition 0.000 description 11
- 238000007127 saponification reaction Methods 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 125000003545 alkoxy group Chemical group 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- 210000004556 brain Anatomy 0.000 description 10
- UEXQBEVWFZKHNB-UHFFFAOYSA-N intermediate 29 Natural products C1=CC(N)=CC=C1NC1=NC=CC=N1 UEXQBEVWFZKHNB-UHFFFAOYSA-N 0.000 description 10
- 230000000670 limiting effect Effects 0.000 description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- NSILYQWHARROMG-QMMMGPOBSA-N tert-butyl (3s)-3-(hydroxymethyl)piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN[C@H](CO)C1 NSILYQWHARROMG-QMMMGPOBSA-N 0.000 description 10
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 239000008346 aqueous phase Substances 0.000 description 9
- 235000019253 formic acid Nutrition 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- VIUDWLLKFANPLX-UHFFFAOYSA-N 2-chloro-3-methoxybenzoic acid Chemical compound COC1=CC=CC(C(O)=O)=C1Cl VIUDWLLKFANPLX-UHFFFAOYSA-N 0.000 description 8
- HNDMZOCUYWBPNO-UHFFFAOYSA-N ClC1=C(C(=O)O)C=CC=C1C=1C(=NNC=1)F Chemical compound ClC1=C(C(=O)O)C=CC=C1C=1C(=NNC=1)F HNDMZOCUYWBPNO-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 229910052731 fluorine Inorganic materials 0.000 description 8
- 239000011737 fluorine Substances 0.000 description 8
- 150000002780 morpholines Chemical class 0.000 description 8
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- FBCNRCVXBGRPQU-UHFFFAOYSA-N bromo benzoate Chemical compound BrOC(=O)C1=CC=CC=C1 FBCNRCVXBGRPQU-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- 150000002576 ketones Chemical class 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 7
- MMWRGWQTAMNAFC-UHFFFAOYSA-N 1,2-dihydropyridine Chemical compound C1NC=CC=C1 MMWRGWQTAMNAFC-UHFFFAOYSA-N 0.000 description 6
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 6
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 6
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 6
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 6
- 150000001200 N-acyl ethanolamides Chemical class 0.000 description 6
- 235000019502 Orange oil Nutrition 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000012391 XPhos Pd G2 Substances 0.000 description 6
- 230000004913 activation Effects 0.000 description 6
- 239000002671 adjuvant Substances 0.000 description 6
- 239000002621 endocannabinoid Substances 0.000 description 6
- 239000006260 foam Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 150000002430 hydrocarbons Chemical group 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 125000002950 monocyclic group Chemical group 0.000 description 6
- 239000010502 orange oil Substances 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 230000002441 reversible effect Effects 0.000 description 6
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 6
- AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical compound CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 description 6
- 229920002554 vinyl polymer Polymers 0.000 description 6
- KGGFKHRLZDJONJ-FPTDNZKUSA-N C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=C(NN=C4)F)(C5=CN=C(C=C5)C(F)(F)F)O Chemical compound C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=C(NN=C4)F)(C5=CN=C(C=C5)C(F)(F)F)O KGGFKHRLZDJONJ-FPTDNZKUSA-N 0.000 description 5
- FRMDDRBLQJCTOR-LIRRHRJNSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=CC(=C(C=C4)F)Br Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=CC(=C(C=C4)F)Br FRMDDRBLQJCTOR-LIRRHRJNSA-N 0.000 description 5
- WERBFSIHUPCGHR-UHFFFAOYSA-N COC1=CC=CC(C(N(CC2)CC3N2CC(C(C=C2)=NC=C2Br)OC3)=O)=C1Cl Chemical compound COC1=CC=CC(C(N(CC2)CC3N2CC(C(C=C2)=NC=C2Br)OC3)=O)=C1Cl WERBFSIHUPCGHR-UHFFFAOYSA-N 0.000 description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 5
- QDWOJUPBEBRUIV-UHFFFAOYSA-N ClC1=C(C=CC=C1OC)C(=O)N1CC2COC(CN2CC1)C=1C=NC=C(C=1)Cl Chemical compound ClC1=C(C=CC=C1OC)C(=O)N1CC2COC(CN2CC1)C=1C=NC=C(C=1)Cl QDWOJUPBEBRUIV-UHFFFAOYSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 108090001060 Lipase Proteins 0.000 description 5
- 102000004882 Lipase Human genes 0.000 description 5
- 239000004367 Lipase Substances 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 5
- 239000012298 atmosphere Substances 0.000 description 5
- 239000004327 boric acid Substances 0.000 description 5
- 210000003169 central nervous system Anatomy 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 5
- 239000007822 coupling agent Substances 0.000 description 5
- 238000010511 deprotection reaction Methods 0.000 description 5
- 239000002158 endotoxin Substances 0.000 description 5
- 239000003112 inhibitor Substances 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 235000019421 lipase Nutrition 0.000 description 5
- 229920006008 lipopolysaccharide Polymers 0.000 description 5
- 239000007937 lozenge Substances 0.000 description 5
- 239000008176 lyophilized powder Substances 0.000 description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 5
- 210000000653 nervous system Anatomy 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 239000000376 reactant Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 4
- PQDRWMYDXMMMBP-UHFFFAOYSA-N 2-oxoicosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCC(=O)C(O)=O PQDRWMYDXMMMBP-UHFFFAOYSA-N 0.000 description 4
- LNURMIDMOXCNEH-UHFFFAOYSA-N 3-bromo-2-chlorobenzoic acid Chemical compound OC(=O)C1=CC=CC(Br)=C1Cl LNURMIDMOXCNEH-UHFFFAOYSA-N 0.000 description 4
- DWOZNANUEDYIOF-UHFFFAOYSA-L 4-ditert-butylphosphanyl-n,n-dimethylaniline;dichloropalladium Chemical compound Cl[Pd]Cl.CN(C)C1=CC=C(P(C(C)(C)C)C(C)(C)C)C=C1.CN(C)C1=CC=C(P(C(C)(C)C)C(C)(C)C)C=C1 DWOZNANUEDYIOF-UHFFFAOYSA-L 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 4
- TWGGPEYWMQSGIL-JTSKRJEESA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CC(=O)NC=C5 Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CC(=O)NC=C5 TWGGPEYWMQSGIL-JTSKRJEESA-N 0.000 description 4
- ATBPOOGJBUHICR-PSLXWICFSA-N C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=C(NN=C4)F)(C5=CC(=C(C=C5)F)F)O Chemical compound C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=C(NN=C4)F)(C5=CC(=C(C=C5)F)F)O ATBPOOGJBUHICR-PSLXWICFSA-N 0.000 description 4
- LOVBWAGHJKMUFM-UHFFFAOYSA-N ClC1=C(C=CC=C1OC)C(=O)N1CC(NCC1)CO Chemical compound ClC1=C(C=CC=C1OC)C(=O)N1CC(NCC1)CO LOVBWAGHJKMUFM-UHFFFAOYSA-N 0.000 description 4
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical compound [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 description 4
- 239000005977 Ethylene Substances 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- LXWZBTGCXJZMBJ-GWCFXTLKSA-N FC(C=CC([C@H]1OC[C@H](CNCC2)N2C1)=C1)=C1Cl Chemical compound FC(C=CC([C@H]1OC[C@H](CNCC2)N2C1)=C1)=C1Cl LXWZBTGCXJZMBJ-GWCFXTLKSA-N 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- KFJXTACZTALWEB-UHFFFAOYSA-N benzoic acid;boric acid Chemical compound OB(O)O.OC(=O)C1=CC=CC=C1 KFJXTACZTALWEB-UHFFFAOYSA-N 0.000 description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 4
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 4
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 150000002066 eicosanoids Chemical class 0.000 description 4
- 239000007903 gelatin capsule Substances 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- DBTNVRCCIDISMV-UHFFFAOYSA-L lithium;magnesium;propane;dichloride Chemical compound [Li+].[Mg+2].[Cl-].[Cl-].C[CH-]C DBTNVRCCIDISMV-UHFFFAOYSA-L 0.000 description 4
- 210000000274 microglia Anatomy 0.000 description 4
- 210000004498 neuroglial cell Anatomy 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 229910052763 palladium Inorganic materials 0.000 description 4
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 235000011056 potassium acetate Nutrition 0.000 description 4
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 4
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical group C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- 150000003852 triazoles Chemical class 0.000 description 4
- YZXBAPSDXZZRGB-PNXWREOESA-N (5z,8z,11z,14z)-2,2,3,3,4,4,5,6-octadeuterioicosa-5,8,11,14-tetraenoic acid Chemical compound OC(=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C(/[2H])=C(/[2H])C\C=C/C\C=C/C\C=C/CCCCC YZXBAPSDXZZRGB-PNXWREOESA-N 0.000 description 3
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 3
- JOCPGHGWUUBURW-UHFFFAOYSA-N 2-bromo-1-(3-chloro-4-fluorophenyl)ethanone Chemical compound FC1=CC=C(C(=O)CBr)C=C1Cl JOCPGHGWUUBURW-UHFFFAOYSA-N 0.000 description 3
- JMUKUVDYZQDUSP-UHFFFAOYSA-N 2-bromo-1-[4-(difluoromethoxy)phenyl]ethanone Chemical compound FC(F)OC1=CC=C(C(=O)CBr)C=C1 JMUKUVDYZQDUSP-UHFFFAOYSA-N 0.000 description 3
- DQZXNWLSEYAXOQ-UHFFFAOYSA-N 2-bromo-1-[6-(trifluoromethyl)pyridin-2-yl]ethanone Chemical compound FC(F)(F)C1=CC=CC(C(=O)CBr)=N1 DQZXNWLSEYAXOQ-UHFFFAOYSA-N 0.000 description 3
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 description 3
- DSMSQFNGAMOGCW-UHFFFAOYSA-N 4-bromo-5-fluoro-1h-pyrazole Chemical compound FC=1NN=CC=1Br DSMSQFNGAMOGCW-UHFFFAOYSA-N 0.000 description 3
- IQTHEAQKKVAXGV-UHFFFAOYSA-N 4-ditert-butylphosphanyl-n,n-dimethylaniline Chemical compound CN(C)C1=CC=C(P(C(C)(C)C)C(C)(C)C)C=C1 IQTHEAQKKVAXGV-UHFFFAOYSA-N 0.000 description 3
- OCSLDGKGXQLMRP-UHFFFAOYSA-N 5-chloro-3-(oxiran-2-yl)-2-phenylmethoxypyridine Chemical compound C(C1=CC=CC=C1)OC1=NC=C(C=C1C1OC1)Cl OCSLDGKGXQLMRP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- JZFJJSSDTZSYRF-BTYIYWSLSA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=C(C(=CC=C4)N5CC(C5)O)Cl Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=C(C(=CC=C4)N5CC(C5)O)Cl JZFJJSSDTZSYRF-BTYIYWSLSA-N 0.000 description 3
- IIIPWBCKEMWEFT-UWJYYQICSA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4)C5=C(NN=C5)C(F)(F)F Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4)C5=C(NN=C5)C(F)(F)F IIIPWBCKEMWEFT-UWJYYQICSA-N 0.000 description 3
- WWCJECOMJWWQAP-BTYIYWSLSA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CN=CN5 Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CN=CN5 WWCJECOMJWWQAP-BTYIYWSLSA-N 0.000 description 3
- GBVKUXMBCPQAJN-JTSKRJEESA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CNC(=O)C=C5 Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CNC(=O)C=C5 GBVKUXMBCPQAJN-JTSKRJEESA-N 0.000 description 3
- WRJHLWKKWKTCCI-UWJYYQICSA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=CNC3=O)Cl)C(=O)C4=CC(=CC(=C4Cl)C5=CNC(=C5)C#N)F Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=CNC3=O)Cl)C(=O)C4=CC(=CC(=C4Cl)C5=CNC(=C5)C#N)F WRJHLWKKWKTCCI-UWJYYQICSA-N 0.000 description 3
- MEVWFIYKADFWTN-SBUREZEXSA-N C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3)C4=C(NN=C4)F)(C5=CC(=C(C=C5)F)F)O Chemical compound C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3)C4=C(NN=C4)F)(C5=CC(=C(C=C5)F)F)O MEVWFIYKADFWTN-SBUREZEXSA-N 0.000 description 3
- VRHOLBVHNSEZOO-JTSKRJEESA-N C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3)C4=C(NN=C4)F)(C5=CN=C(C=C5)C(F)(F)F)O Chemical compound C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3)C4=C(NN=C4)F)(C5=CN=C(C=C5)C(F)(F)F)O VRHOLBVHNSEZOO-JTSKRJEESA-N 0.000 description 3
- VXCOKGABIXNKEO-FPTDNZKUSA-N C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=C(NN=C4)F)(C5=CN=C(C=C5)C(F)(F)F)F Chemical compound C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=C(NN=C4)F)(C5=CN=C(C=C5)C(F)(F)F)F VXCOKGABIXNKEO-FPTDNZKUSA-N 0.000 description 3
- XSXDQEIFCACPDW-FPTDNZKUSA-N C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=C(NN=C4)F)(C5=NC=C(C=C5)C(F)(F)F)O Chemical compound C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=C(NN=C4)F)(C5=NC=C(C=C5)C(F)(F)F)O XSXDQEIFCACPDW-FPTDNZKUSA-N 0.000 description 3
- QNSCFKNXIFSQFV-AOMKIAJQSA-N C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=CNN=C4)(C5=CN=C(C=C5)C(F)(F)F)O Chemical compound C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=CNN=C4)(C5=CN=C(C=C5)C(F)(F)F)O QNSCFKNXIFSQFV-AOMKIAJQSA-N 0.000 description 3
- SCSUEXVIYODBKQ-UHFFFAOYSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3CC(OCC3C2)C4=CC5=C(CC5)C=C4 Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3CC(OCC3C2)C4=CC5=C(CC5)C=C4 SCSUEXVIYODBKQ-UHFFFAOYSA-N 0.000 description 3
- VRODCAAYVWNGKG-KTQQKIMGSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3CC(SC[C@@H]3C2)C4=CC(=C(C=C4)F)Cl Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3CC(SC[C@@H]3C2)C4=CC(=C(C=C4)F)Cl VRODCAAYVWNGKG-KTQQKIMGSA-N 0.000 description 3
- VXXJMEFDRMETTG-KBXCAEBGSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@@H](OC[C@@H]3C2)C4=NC=CC(=C4)Cl Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@@H](OC[C@@H]3C2)C4=NC=CC(=C4)Cl VXXJMEFDRMETTG-KBXCAEBGSA-N 0.000 description 3
- QSFNFSIVYQYQPE-SPLOXXLWSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@@](OC[C@H]3C2)(C4=CC(=C(C=C4)F)Cl)O Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@@](OC[C@H]3C2)(C4=CC(=C(C=C4)F)Cl)O QSFNFSIVYQYQPE-SPLOXXLWSA-N 0.000 description 3
- ZXTRXHZSSOQTAT-LIRRHRJNSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=CC(=C(C=C4)F)Cl Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=CC(=C(C=C4)F)Cl ZXTRXHZSSOQTAT-LIRRHRJNSA-N 0.000 description 3
- KJSHOFZHBWYQFE-SGTLLEGYSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=NC=C(C(=C4)C(F)(F)F)Cl Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=NC=C(C(=C4)C(F)(F)F)Cl KJSHOFZHBWYQFE-SGTLLEGYSA-N 0.000 description 3
- DVQDOIGPGUKRPD-SGTLLEGYSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=NC=C(C(=C4)C(F)(F)F)F Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=NC=C(C(=C4)C(F)(F)F)F DVQDOIGPGUKRPD-SGTLLEGYSA-N 0.000 description 3
- QSFNFSIVYQYQPE-QKKBWIMNSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC(=C(C=C4)F)Cl)O Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC(=C(C=C4)F)Cl)O QSFNFSIVYQYQPE-QKKBWIMNSA-N 0.000 description 3
- IIXDVGWTRGEVTC-LIRRHRJNSA-N COC1=CC=CC(=C1F)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=CC(=C(C=C4)F)Cl Chemical compound COC1=CC=CC(=C1F)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=CC(=C(C=C4)F)Cl IIXDVGWTRGEVTC-LIRRHRJNSA-N 0.000 description 3
- 102100036214 Cannabinoid receptor 2 Human genes 0.000 description 3
- 101710187022 Cannabinoid receptor 2 Proteins 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- QKDDFCAPUNDPCP-VIFPVBQESA-N ClC1=C(C=CC=C1C=1C(=NNC=1)F)C(=O)N1C[C@H](NCC1)CO Chemical compound ClC1=C(C=CC=C1C=1C(=NNC=1)F)C(=O)N1C[C@H](NCC1)CO QKDDFCAPUNDPCP-VIFPVBQESA-N 0.000 description 3
- AUGDWZDCGLPOJT-KZULUSFZSA-N ClC1=C(C=CC=C1OC)C(=O)N1C[C@@H]2CO[C@H](CN2CC1)C1=NC=C(C(=C1)Cl)Cl Chemical compound ClC1=C(C=CC=C1OC)C(=O)N1C[C@@H]2CO[C@H](CN2CC1)C1=NC=C(C(=C1)Cl)Cl AUGDWZDCGLPOJT-KZULUSFZSA-N 0.000 description 3
- HSZDNOUQOHGWPX-SGTLLEGYSA-N ClC1=C(C=CC=C1OC)C(=O)N1C[C@H]2CO[C@@H](CN2CC1)C1=NC=C(C(=C1)Br)Cl Chemical compound ClC1=C(C=CC=C1OC)C(=O)N1C[C@H]2CO[C@@H](CN2CC1)C1=NC=C(C(=C1)Br)Cl HSZDNOUQOHGWPX-SGTLLEGYSA-N 0.000 description 3
- MAPJVUNULMKOAL-UGSOOPFHSA-N ClC1=C(C=CC=C1OC)C(=O)N1C[C@H]2CO[C@@H](CN2CC1)C1=NC=CC(=C1)OC(F)(F)F Chemical compound ClC1=C(C=CC=C1OC)C(=O)N1C[C@H]2CO[C@@H](CN2CC1)C1=NC=CC(=C1)OC(F)(F)F MAPJVUNULMKOAL-UGSOOPFHSA-N 0.000 description 3
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 3
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- GLTCFHLMTQIRNO-GWCFXTLKSA-N O[C@]1(C(C=C2)=CC(Cl)=C2F)OC[C@H](CNCC2)N2C1 Chemical compound O[C@]1(C(C=C2)=CC(Cl)=C2F)OC[C@H](CNCC2)N2C1 GLTCFHLMTQIRNO-GWCFXTLKSA-N 0.000 description 3
- HBMPLMPEOWMJFX-OWJWWREXSA-N O[C@]1(C(C=C2)=CC=C2OC(F)F)OC[C@H](CN(CC2)C(C(C=CC=C3C4=CNN=C4F)=C3Cl)=O)N2C1 Chemical compound O[C@]1(C(C=C2)=CC=C2OC(F)F)OC[C@H](CN(CC2)C(C(C=CC=C3C4=CNN=C4F)=C3Cl)=O)N2C1 HBMPLMPEOWMJFX-OWJWWREXSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 3
- XALSENDNXLAGGF-XOBRGWDASA-N [(3R,9aS)-3-(3,4-difluorophenyl)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-[2-chloro-3-(5-fluoro-1H-pyrazol-4-yl)phenyl]methanone Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)F)C(=O)C4=CC=CC(=C4Cl)C5=C(NN=C5)F XALSENDNXLAGGF-XOBRGWDASA-N 0.000 description 3
- 150000001502 aryl halides Chemical class 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- 125000002619 bicyclic group Chemical group 0.000 description 3
- NMJJFJNHVMGPGM-UHFFFAOYSA-N butyl formate Chemical group CCCCOC=O NMJJFJNHVMGPGM-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000008298 dragée Substances 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 238000006266 etherification reaction Methods 0.000 description 3
- 125000004438 haloalkoxy group Chemical group 0.000 description 3
- 125000001188 haloalkyl group Chemical group 0.000 description 3
- 125000005842 heteroatom Chemical group 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 150000002617 leukotrienes Chemical class 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- IUYHWZFSGMZEOG-UHFFFAOYSA-M magnesium;propane;chloride Chemical compound [Mg+2].[Cl-].C[CH-]C IUYHWZFSGMZEOG-UHFFFAOYSA-M 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 3
- 150000003180 prostaglandins Chemical class 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000004576 sand Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- RUPAXCPQAAOIPB-UHFFFAOYSA-N tert-butyl formate Chemical group CC(C)(C)OC=O RUPAXCPQAAOIPB-UHFFFAOYSA-N 0.000 description 3
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- ANTZQPOLKFIXDA-YFKPBYRVSA-N (3s)-3-(hydroxymethyl)piperazine-1-carboxylic acid Chemical compound OC[C@@H]1CN(C(O)=O)CCN1 ANTZQPOLKFIXDA-YFKPBYRVSA-N 0.000 description 2
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 2
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 2
- ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 description 2
- QGRPVMLBTFGQDQ-UHFFFAOYSA-N 1-chloro-2-methoxybenzene Chemical compound COC1=CC=CC=C1Cl QGRPVMLBTFGQDQ-UHFFFAOYSA-N 0.000 description 2
- MNZAKDODWSQONA-UHFFFAOYSA-N 1-dibutylphosphorylbutane Chemical compound CCCCP(=O)(CCCC)CCCC MNZAKDODWSQONA-UHFFFAOYSA-N 0.000 description 2
- ZEMZPXWZVTUONV-UHFFFAOYSA-N 2-(2-dicyclohexylphosphanylphenyl)-n,n-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 ZEMZPXWZVTUONV-UHFFFAOYSA-N 0.000 description 2
- LZGFKXPCCHIYQH-UHFFFAOYSA-N 2-(oxiran-2-yl)-4-(trifluoromethoxy)pyridine Chemical compound O1C(C1)C1=NC=CC(=C1)OC(F)(F)F LZGFKXPCCHIYQH-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- UQYLSZRIAXYWHK-UHFFFAOYSA-N 2-bromo-1-(3-bromo-2-chlorophenyl)ethanone Chemical compound Clc1c(Br)cccc1C(=O)CBr UQYLSZRIAXYWHK-UHFFFAOYSA-N 0.000 description 2
- UMQJAFDUZIGZMO-UHFFFAOYSA-N 2-chloro-3,5-dimethoxybenzoic acid Chemical compound COC1=CC(OC)=C(Cl)C(C(O)=O)=C1 UMQJAFDUZIGZMO-UHFFFAOYSA-N 0.000 description 2
- CLLRXKFCVVIULX-UHFFFAOYSA-N 2-chloro-3-(1,3-oxazol-5-yl)benzoic acid Chemical compound ClC1=C(C(=O)O)C=CC=C1C1=CN=CO1 CLLRXKFCVVIULX-UHFFFAOYSA-N 0.000 description 2
- DCFKRHZDCZVCFL-UHFFFAOYSA-N 2-ethenyl-4-(trifluoromethoxy)pyridine Chemical compound FC(OC1=CC(=NC=C1)C=C)(F)F DCFKRHZDCZVCFL-UHFFFAOYSA-N 0.000 description 2
- HPZCYYGYTXBRMZ-UHFFFAOYSA-N 2-ethenyl-5-fluoro-4-(trifluoromethyl)pyridine Chemical compound FC=1C(=CC(=NC=1)C=C)C(F)(F)F HPZCYYGYTXBRMZ-UHFFFAOYSA-N 0.000 description 2
- SLGLWYWKBXLDAU-UHFFFAOYSA-N 2-fluoro-3-(5-fluoro-1H-pyrazol-4-yl)benzoic acid Chemical compound FC1=C(C(=O)O)C=CC=C1C=1C(=NNC=1)F SLGLWYWKBXLDAU-UHFFFAOYSA-N 0.000 description 2
- LFXNSKIESHOTNN-UHFFFAOYSA-N 2-fluoro-5-(oxiran-2-yl)benzonitrile Chemical compound FC1=C(C#N)C=C(C=C1)C1OC1 LFXNSKIESHOTNN-UHFFFAOYSA-N 0.000 description 2
- DRYCDAQQSZXIMB-UHFFFAOYSA-N 2-methoxy-3-(oxiran-2-yl)-6-(trifluoromethyl)pyridine Chemical compound COC1=NC(=CC=C1C1OC1)C(F)(F)F DRYCDAQQSZXIMB-UHFFFAOYSA-N 0.000 description 2
- VNCIESPHQGBEKA-UHFFFAOYSA-N 3-bromo-5-chloro-2-phenylmethoxypyridine Chemical compound BrC1=CC(Cl)=CN=C1OCC1=CC=CC=C1 VNCIESPHQGBEKA-UHFFFAOYSA-N 0.000 description 2
- ZTOYBFPYQXBWDY-UHFFFAOYSA-N 3-chloro-6-(oxiran-2-yl)-2-(trifluoromethyl)pyridine Chemical group ClC=1C(=NC(=CC=1)C1OC1)C(F)(F)F ZTOYBFPYQXBWDY-UHFFFAOYSA-N 0.000 description 2
- LCYATYMNSVLLSL-UHFFFAOYSA-N 3-chloro-6-ethenyl-2-(trifluoromethyl)pyridine Chemical compound ClC=1C(=NC(=CC=1)C=C)C(F)(F)F LCYATYMNSVLLSL-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- RTRXINWBAJFEEX-UHFFFAOYSA-N 3-ethenyl-2-methoxy-6-(trifluoromethyl)pyridine Chemical compound COC1=NC(=CC=C1C=C)C(F)(F)F RTRXINWBAJFEEX-UHFFFAOYSA-N 0.000 description 2
- FDSZDGPNAWKFLH-UHFFFAOYSA-N 3-ethenyl-6-(trifluoromethyl)pyridazine Chemical compound FC(C=1N=NC(=CC=1)C=C)(F)F FDSZDGPNAWKFLH-UHFFFAOYSA-N 0.000 description 2
- JCBMEGZOEVHGLS-UHFFFAOYSA-N 4,5-dichloro-2-(oxiran-2-yl)pyridine Chemical compound ClC1=CC(=NC=C1Cl)C1OC1 JCBMEGZOEVHGLS-UHFFFAOYSA-N 0.000 description 2
- VNTXUFLTYYQIPQ-UHFFFAOYSA-N 4,5-dichloro-2-ethenylpyridine Chemical compound C(=C)C1=NC=C(C(=C1)Cl)Cl VNTXUFLTYYQIPQ-UHFFFAOYSA-N 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- MDGARDUARHMMAR-UHFFFAOYSA-N 4-bromo-1h-pyrrole-2-carbonitrile Chemical compound BrC1=CNC(C#N)=C1 MDGARDUARHMMAR-UHFFFAOYSA-N 0.000 description 2
- PYYNRTIIWUCASJ-UHFFFAOYSA-N 4-bromo-5-chloro-2-(oxiran-2-yl)pyridine Chemical compound BrC1=CC(=NC=C1Cl)C1OC1 PYYNRTIIWUCASJ-UHFFFAOYSA-N 0.000 description 2
- VBWHVOZPVXKGHE-UHFFFAOYSA-N 4-bromo-5-chloro-2-ethenylpyridine Chemical compound BrC1=CC(=NC=C1Cl)C=C VBWHVOZPVXKGHE-UHFFFAOYSA-N 0.000 description 2
- GNBXAAYHNOXGQT-UHFFFAOYSA-N 4-chloro-5-phenylmethoxypyridazine Chemical compound C(C1=CC=CC=C1)OC1=CN=NC=C1Cl GNBXAAYHNOXGQT-UHFFFAOYSA-N 0.000 description 2
- MTHKPXWMRVVEPC-UHFFFAOYSA-N 4-methoxy-5-(oxiran-2-yl)-2-(trifluoromethyl)pyridine Chemical compound COC1=CC(=NC=C1C1OC1)C(F)(F)F MTHKPXWMRVVEPC-UHFFFAOYSA-N 0.000 description 2
- VADCCYKSLLOFPG-UHFFFAOYSA-N 5-(3-bromo-2-chlorophenyl)-3H-1,3-oxazol-2-one Chemical compound BrC=1C(=C(C=CC=1)C1=CNC(O1)=O)Cl VADCCYKSLLOFPG-UHFFFAOYSA-N 0.000 description 2
- BMKMUFGBINIIPQ-UHFFFAOYSA-N 5-bromo-1H-pyrazole-3-carboxamide Chemical compound BrC1=CC(=NN1)C(=O)N BMKMUFGBINIIPQ-UHFFFAOYSA-N 0.000 description 2
- QYOYKFCCKGWXGH-UHFFFAOYSA-N 5-bromo-2-(oxiran-2-yl)pyridine Chemical compound N1=CC(Br)=CC=C1C1OC1 QYOYKFCCKGWXGH-UHFFFAOYSA-N 0.000 description 2
- GYPXHRMMOKTJLW-UHFFFAOYSA-N 5-chloro-2-ethenyl-4-(trifluoromethyl)pyridine Chemical compound ClC=1C(=CC(=NC=1)C=C)C(F)(F)F GYPXHRMMOKTJLW-UHFFFAOYSA-N 0.000 description 2
- PMABUZCFBRYHEU-UHFFFAOYSA-N 5-chloro-2-ethenyl-4-methylpyridine Chemical compound CC1=CC(C=C)=NC=C1Cl PMABUZCFBRYHEU-UHFFFAOYSA-N 0.000 description 2
- NBJFHVGIZXRAET-UHFFFAOYSA-N 5-chloro-4-(difluoromethyl)-2-(oxiran-2-yl)pyridine Chemical compound ClC=1C(=CC(=NC=1)C1OC1)C(F)F NBJFHVGIZXRAET-UHFFFAOYSA-N 0.000 description 2
- UJZAHUOWXRXHEH-UHFFFAOYSA-N 5-chloro-4-(difluoromethyl)-2-ethenylpyridine Chemical compound ClC=1C(=CC(=NC=1)C=C)C(F)F UJZAHUOWXRXHEH-UHFFFAOYSA-N 0.000 description 2
- DRMCSJACTSFPSD-UHFFFAOYSA-N 5-ethenyl-2-fluorobenzonitrile Chemical compound FC1=CC=C(C=C)C=C1C#N DRMCSJACTSFPSD-UHFFFAOYSA-N 0.000 description 2
- FXRAIGZDODZOAH-UHFFFAOYSA-N 5-ethenyl-4-methoxy-2-(trifluoromethyl)pyridine Chemical compound COC1=CC(=NC=C1C=C)C(F)(F)F FXRAIGZDODZOAH-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WDPVYIBCSWFBQV-UHFFFAOYSA-N BrC1=CC(C#N)=NN1 Chemical compound BrC1=CC(C#N)=NN1 WDPVYIBCSWFBQV-UHFFFAOYSA-N 0.000 description 2
- WWJWGDSEIJXDHG-KNVGNIICSA-N BrC=1C=C(C=CC=1F)C(CN1[C@@H](CN(CC1)C(=O)OC(C)(C)C)CO)O Chemical compound BrC=1C=C(C=CC=1F)C(CN1[C@@H](CN(CC1)C(=O)OC(C)(C)C)CO)O WWJWGDSEIJXDHG-KNVGNIICSA-N 0.000 description 2
- NJSCJKVJFOMWPP-PMYAAIEVSA-N C/C=C/C1=C(C=CC(=C1)[C@@H]2CN3CCN(C[C@H]3CO2)C(=O)C4=C(C(=CC=C4)OC)Cl)F Chemical compound C/C=C/C1=C(C=CC(=C1)[C@@H]2CN3CCN(C[C@H]3CO2)C(=O)C4=C(C(=CC=C4)OC)Cl)F NJSCJKVJFOMWPP-PMYAAIEVSA-N 0.000 description 2
- INFWJKFUZPCQNV-KKSFZXQISA-N C1CN(CC(=O)N1)C2=CC=CC(=C2Cl)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl Chemical compound C1CN(CC(=O)N1)C2=CC=CC(=C2Cl)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl INFWJKFUZPCQNV-KKSFZXQISA-N 0.000 description 2
- XALSENDNXLAGGF-VBKZILBWSA-N C1CN(C[C@@H]2N1C[C@@H](OC2)C3=CC(=C(C=C3)F)F)C(=O)C4=CC=CC(=C4Cl)C5=C(NN=C5)F Chemical compound C1CN(C[C@@H]2N1C[C@@H](OC2)C3=CC(=C(C=C3)F)F)C(=O)C4=CC=CC(=C4Cl)C5=C(NN=C5)F XALSENDNXLAGGF-VBKZILBWSA-N 0.000 description 2
- SXVPHUYDOPDTDA-HRAATJIYSA-N C1CN(C[C@@H]2N1C[C@@H](OC2)C3=CNC(=CC3=O)C(F)(F)F)C(=O)C4=CC(=CC(=C4Cl)C5=CNC(=C5)C#N)F Chemical compound C1CN(C[C@@H]2N1C[C@@H](OC2)C3=CNC(=CC3=O)C(F)(F)F)C(=O)C4=CC(=CC(=C4Cl)C5=CNC(=C5)C#N)F SXVPHUYDOPDTDA-HRAATJIYSA-N 0.000 description 2
- GGQXASIKVBEHQG-XOBRGWDASA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)Cl)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CNC(=O)O5 Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)Cl)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CNC(=O)O5 GGQXASIKVBEHQG-XOBRGWDASA-N 0.000 description 2
- NKJAKQFWLFITRF-JTSKRJEESA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC(=CC(=C4Cl)C5=CC(=O)NC=C5)F Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC(=CC(=C4Cl)C5=CC(=O)NC=C5)F NKJAKQFWLFITRF-JTSKRJEESA-N 0.000 description 2
- VSOGRAMKPMPHGJ-AOMKIAJQSA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CC(=NN5)C#N Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CC(=NN5)C#N VSOGRAMKPMPHGJ-AOMKIAJQSA-N 0.000 description 2
- JBMHZKFLOSVHHO-SBUREZEXSA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CC=CC=N5 Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CC=CC=N5 JBMHZKFLOSVHHO-SBUREZEXSA-N 0.000 description 2
- KBYAMOITUMBJDU-XOBRGWDASA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CNC(=O)O5 Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CNC(=O)O5 KBYAMOITUMBJDU-XOBRGWDASA-N 0.000 description 2
- FNSODQPCQXOKRM-KKSFZXQISA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CNN=C5 Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CNN=C5 FNSODQPCQXOKRM-KKSFZXQISA-N 0.000 description 2
- HFWHCFIUDZXCQE-NYHFZMIOSA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CNN=CC5=O Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CNN=CC5=O HFWHCFIUDZXCQE-NYHFZMIOSA-N 0.000 description 2
- SVAORSXGKBXWFL-AOMKIAJQSA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=NN=CC=C5 Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=NN=CC=C5 SVAORSXGKBXWFL-AOMKIAJQSA-N 0.000 description 2
- UJNBKHRLULMNIR-UGSOOPFHSA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=NNC(=O)O5 Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=NNC(=O)O5 UJNBKHRLULMNIR-UGSOOPFHSA-N 0.000 description 2
- QKJJGKHZTWRYKT-XOBRGWDASA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=NNN=C5 Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=NNN=C5 QKJJGKHZTWRYKT-XOBRGWDASA-N 0.000 description 2
- UZZNNSPRLJBVBP-XOBRGWDASA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4F)C5=C(NN=C5)C(F)(F)F Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4F)C5=C(NN=C5)C(F)(F)F UZZNNSPRLJBVBP-XOBRGWDASA-N 0.000 description 2
- HUNCXXQHTRXAPQ-UWJYYQICSA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=CNC3=O)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CNC(=C5)C#N Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=CNC3=O)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CNC(=C5)C#N HUNCXXQHTRXAPQ-UWJYYQICSA-N 0.000 description 2
- BJXASEPEDGKAMP-AWEZNQCLSA-N C1CN2C=C(OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=C(NN=C4)F)C5=NC=C(C=C5)C(F)(F)F Chemical compound C1CN2C=C(OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=C(NN=C4)F)C5=NC=C(C=C5)C(F)(F)F BJXASEPEDGKAMP-AWEZNQCLSA-N 0.000 description 2
- ABAPXZONGGKSLI-WNSKOXEYSA-N C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=C(NN=C4)C#N)(C5=CN=C(C=C5)C(F)(F)F)O Chemical compound C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=C(NN=C4)C#N)(C5=CN=C(C=C5)C(F)(F)F)O ABAPXZONGGKSLI-WNSKOXEYSA-N 0.000 description 2
- NEXGLIJXEQTVIU-BVZFJXPGSA-N C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=CNC(=C4)C#N)(C5=CC(=C(C=C5)F)Cl)O Chemical compound C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=CNC(=C4)C#N)(C5=CC(=C(C=C5)F)Cl)O NEXGLIJXEQTVIU-BVZFJXPGSA-N 0.000 description 2
- CTIDOLGZMWBHFP-BVZFJXPGSA-N C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=CNC(=C4)C#N)(C5=CC(=C(C=C5)F)F)O Chemical compound C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=CNC(=C4)C#N)(C5=CC(=C(C=C5)F)F)O CTIDOLGZMWBHFP-BVZFJXPGSA-N 0.000 description 2
- XFYWJBFTPQFFLH-PSLXWICFSA-N C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=CNC(=O)O4)(C5=CC(=C(C=C5)Cl)Cl)O Chemical compound C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=CNC(=O)O4)(C5=CC(=C(C=C5)Cl)Cl)O XFYWJBFTPQFFLH-PSLXWICFSA-N 0.000 description 2
- QRUUHRRLJYFRPM-NYHFZMIOSA-N C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=COC=N4)(C5=NC=C(C=C5)C(F)(F)F)O Chemical compound C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=COC=N4)(C5=NC=C(C=C5)C(F)(F)F)O QRUUHRRLJYFRPM-NYHFZMIOSA-N 0.000 description 2
- KDZAPYQCTCMOGG-AVRDEDQJSA-N CC#CC1=C(C=CC(=C1)[C@@H]2CN3CCN(C[C@H]3CO2)C(=O)C4=C(C(=CC=C4)OC)Cl)F Chemical compound CC#CC1=C(C=CC(=C1)[C@@H]2CN3CCN(C[C@H]3CO2)C(=O)C4=C(C(=CC=C4)OC)Cl)F KDZAPYQCTCMOGG-AVRDEDQJSA-N 0.000 description 2
- CVMGMKRGYQCXED-KKSFZXQISA-N CC1=C(C(=CC=C1)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=CC(=C(C=C4)F)Cl)C#N Chemical compound CC1=C(C(=CC=C1)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=CC(=C(C=C4)F)Cl)C#N CVMGMKRGYQCXED-KKSFZXQISA-N 0.000 description 2
- WQZSPPWOFRHKIW-SBUREZEXSA-N CC1=C(C=CC(=O)N1)C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl Chemical compound CC1=C(C=CC(=O)N1)C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl WQZSPPWOFRHKIW-SBUREZEXSA-N 0.000 description 2
- LOABTVZICYYALQ-UUOWRZLLSA-N CC1=C(C=NC=C1)C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl Chemical compound CC1=C(C=NC=C1)C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl LOABTVZICYYALQ-UUOWRZLLSA-N 0.000 description 2
- HZASAXBLRXOKLI-AOMKIAJQSA-N CC1=C(C=NN1)C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl Chemical compound CC1=C(C=NN1)C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl HZASAXBLRXOKLI-AOMKIAJQSA-N 0.000 description 2
- JFCAMKSFOKSPFK-SBUREZEXSA-N CC1=C(C=NN1C)C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl Chemical compound CC1=C(C=NN1C)C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl JFCAMKSFOKSPFK-SBUREZEXSA-N 0.000 description 2
- WQDGIYGLMLDQRE-MBSDFSHPSA-N CC1=C(N=CC=C1)C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl Chemical compound CC1=C(N=CC=C1)C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl WQDGIYGLMLDQRE-MBSDFSHPSA-N 0.000 description 2
- WNUGXYASSWHTGL-MBSDFSHPSA-N CC1=CC(=CC(=O)N1)C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl Chemical compound CC1=CC(=CC(=O)N1)C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl WNUGXYASSWHTGL-MBSDFSHPSA-N 0.000 description 2
- COUMWMYHBSXJJI-LIRRHRJNSA-N CC1=CC(=NC=C1Cl)[C@@H]2CN3CCN(C[C@H]3CO2)C(=O)C4=C(C(=CC=C4)OC)Cl Chemical compound CC1=CC(=NC=C1Cl)[C@@H]2CN3CCN(C[C@H]3CO2)C(=O)C4=C(C(=CC=C4)OC)Cl COUMWMYHBSXJJI-LIRRHRJNSA-N 0.000 description 2
- COUMWMYHBSXJJI-IFXJQAMLSA-N CC1=CC(=NC=C1Cl)[C@H]2CN3CCN(C[C@H]3CO2)C(=O)C4=C(C(=CC=C4)OC)Cl Chemical compound CC1=CC(=NC=C1Cl)[C@H]2CN3CCN(C[C@H]3CO2)C(=O)C4=C(C(=CC=C4)OC)Cl COUMWMYHBSXJJI-IFXJQAMLSA-N 0.000 description 2
- NTDQRDDYIOALKS-AOMKIAJQSA-N CC1=NOC=C1C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl Chemical compound CC1=NOC=C1C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl NTDQRDDYIOALKS-AOMKIAJQSA-N 0.000 description 2
- RJPVVODMWWXRMX-WNSKOXEYSA-N CN1C2=CC=CC=C2N=C1[C@@]3(CN4CCN(C[C@H]4CO3)C(=O)C5=C(C(=CC=C5)OC)Cl)O Chemical compound CN1C2=CC=CC=C2N=C1[C@@]3(CN4CCN(C[C@H]4CO3)C(=O)C5=C(C(=CC=C5)OC)Cl)O RJPVVODMWWXRMX-WNSKOXEYSA-N 0.000 description 2
- QTJAEOJKDDUVHW-UHFFFAOYSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C=C(OCC3C2)C4=NC5=CC=CC=C5S4 Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C=C(OCC3C2)C4=NC5=CC=CC=C5S4 QTJAEOJKDDUVHW-UHFFFAOYSA-N 0.000 description 2
- QQMCXNXQEPCXBZ-UHFFFAOYSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3CC(OCC3C2)C4=CC=C(C=C4)C(F)F Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3CC(OCC3C2)C4=CC=C(C=C4)C(F)F QQMCXNXQEPCXBZ-UHFFFAOYSA-N 0.000 description 2
- YZAYGLRWFCHAKX-JLCFBVMHSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@@](OC[C@H]3C2)(C4=NC5=CC=CC=C5N4)O Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@@](OC[C@H]3C2)(C4=NC5=CC=CC=C5N4)O YZAYGLRWFCHAKX-JLCFBVMHSA-N 0.000 description 2
- PBIPSOVRZRICMG-UGSOOPFHSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=C(C(=CC=C4)F)F Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=C(C(=CC=C4)F)F PBIPSOVRZRICMG-UGSOOPFHSA-N 0.000 description 2
- PKOJSIFCMRARMJ-JTSKRJEESA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=CC(=C(C=C4)F)C5CC5 Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=CC(=C(C=C4)F)C5CC5 PKOJSIFCMRARMJ-JTSKRJEESA-N 0.000 description 2
- XIFZOQSNDNPVQL-BUXKBTBVSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=CC(=C(C=C4F)F)F Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=CC(=C(C=C4F)F)F XIFZOQSNDNPVQL-BUXKBTBVSA-N 0.000 description 2
- FEWWNWPHWGITJY-SJCJKPOMSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=NC(=C(C=C4)Cl)C(F)(F)F Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=NC(=C(C=C4)Cl)C(F)(F)F FEWWNWPHWGITJY-SJCJKPOMSA-N 0.000 description 2
- LLPOSPFQVGRKAL-SGTLLEGYSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=NC=C(C(=C4)C(F)F)Cl Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=NC=C(C(=C4)C(F)F)Cl LLPOSPFQVGRKAL-SGTLLEGYSA-N 0.000 description 2
- AUGDWZDCGLPOJT-SGTLLEGYSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=NC=C(C(=C4)Cl)Cl Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=NC=C(C(=C4)Cl)Cl AUGDWZDCGLPOJT-SGTLLEGYSA-N 0.000 description 2
- WWRQQAGVEDFFIK-QKVFXAPYSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC(=C(C=C4F)F)F)O Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC(=C(C=C4F)F)F)O WWRQQAGVEDFFIK-QKVFXAPYSA-N 0.000 description 2
- SLOGJCMSAVKJNR-UUOWRZLLSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC(=CC(=C4)C5=CN=CO5)Cl)O Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC(=CC(=C4)C5=CN=CO5)Cl)O SLOGJCMSAVKJNR-UUOWRZLLSA-N 0.000 description 2
- MGPYWQDQNYXIJX-KKSFZXQISA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC(=CC=C4)C(F)(F)F)O Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC(=CC=C4)C(F)(F)F)O MGPYWQDQNYXIJX-KKSFZXQISA-N 0.000 description 2
- YXZGCSBNLIWKMZ-XDHUDOTRSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC(=NO4)C5=CC=CC=C5)O Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC(=NO4)C5=CC=CC=C5)O YXZGCSBNLIWKMZ-XDHUDOTRSA-N 0.000 description 2
- PHYWKLBCBGTDJF-XDHUDOTRSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CSC(=N4)C5=CC=C(C=C5)F)O Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CSC(=N4)C5=CC=C(C=C5)F)O PHYWKLBCBGTDJF-XDHUDOTRSA-N 0.000 description 2
- YZAYGLRWFCHAKX-FPTDNZKUSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=NC5=CC=CC=C5N4)O Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=NC5=CC=CC=C5N4)O YZAYGLRWFCHAKX-FPTDNZKUSA-N 0.000 description 2
- XGLUSHGUCBNAQF-UHFFFAOYSA-N COC1=CC=CC(C(N(CC2)CC3N2CC(C2=NC(C=CC=C4)=C4S2)(O)OC3)=O)=C1Cl Chemical compound COC1=CC=CC(C(N(CC2)CC3N2CC(C2=NC(C=CC=C4)=C4S2)(O)OC3)=O)=C1Cl XGLUSHGUCBNAQF-UHFFFAOYSA-N 0.000 description 2
- PAPYNRAJWKTWOL-BVZFJXPGSA-N COC1=CC=CC=C1C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl Chemical compound COC1=CC=CC=C1C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl PAPYNRAJWKTWOL-BVZFJXPGSA-N 0.000 description 2
- 102000018208 Cannabinoid Receptor Human genes 0.000 description 2
- 108050007331 Cannabinoid receptor Proteins 0.000 description 2
- XNCJQLQSYJUOPQ-UHFFFAOYSA-N ClC1=C(C(=O)O)C=CC=C1C=1C(=NNC=1)C#N Chemical compound ClC1=C(C(=O)O)C=CC=C1C=1C(=NNC=1)C#N XNCJQLQSYJUOPQ-UHFFFAOYSA-N 0.000 description 2
- OVTDZMAPLDTHQW-UHFFFAOYSA-N ClC1=C(C(=O)OC)C=CC=C1C1=CNC(=C1)C#N Chemical compound ClC1=C(C(=O)OC)C=CC=C1C1=CNC(=C1)C#N OVTDZMAPLDTHQW-UHFFFAOYSA-N 0.000 description 2
- SNSXGECNRTZRSA-UHFFFAOYSA-N ClC1=C(C(=O)OC)C=CC=C1C1=NNC(=C1)C#N Chemical compound ClC1=C(C(=O)OC)C=CC=C1C1=NNC(=C1)C#N SNSXGECNRTZRSA-UHFFFAOYSA-N 0.000 description 2
- MLVMQNFQQLNNOL-UHFFFAOYSA-N ClC1=C(C(=O)OC)C=CC=C1C1=NNC=C1F Chemical compound ClC1=C(C(=O)OC)C=CC=C1C1=NNC=C1F MLVMQNFQQLNNOL-UHFFFAOYSA-N 0.000 description 2
- DIVIZVNFJZMYAK-UHFFFAOYSA-N ClC1=C(C(=O)OC)C=CC=C1C=1C=NNC=1C Chemical compound ClC1=C(C(=O)OC)C=CC=C1C=1C=NNC=1C DIVIZVNFJZMYAK-UHFFFAOYSA-N 0.000 description 2
- OEWGQCXWNIMTAW-PIVQAISJSA-N ClC1=C(C=CC=C1C=1C(=NNC=1)F)C(=O)N1C[C@H]2COC(CN2CC1)C=1C=NC(=CC=1)Br Chemical compound ClC1=C(C=CC=C1C=1C(=NNC=1)F)C(=O)N1C[C@H]2COC(CN2CC1)C=1C=NC(=CC=1)Br OEWGQCXWNIMTAW-PIVQAISJSA-N 0.000 description 2
- LOVBWAGHJKMUFM-VIFPVBQESA-N ClC1=C(C=CC=C1OC)C(=O)N1C[C@H](NCC1)CO Chemical compound ClC1=C(C=CC=C1OC)C(=O)N1C[C@H](NCC1)CO LOVBWAGHJKMUFM-VIFPVBQESA-N 0.000 description 2
- PEZGYSDIPROXBN-XGLRFROISA-N ClC1=C(C=CC=C1OC)C(=O)N1C[C@H]2COC(CN2CC1)C1=CC(=C(C=C1)F)C1=CN(C=C1)C Chemical compound ClC1=C(C=CC=C1OC)C(=O)N1C[C@H]2COC(CN2CC1)C1=CC(=C(C=C1)F)C1=CN(C=C1)C PEZGYSDIPROXBN-XGLRFROISA-N 0.000 description 2
- RIIQAEVCYNHLLI-CISYCMJJSA-N ClC1=C(C=CC=C1OC)C(=O)N1C[C@H]2COC(CN2CC1)C1=CC(=C(C=C1)F)C1=CN=CO1 Chemical compound ClC1=C(C=CC=C1OC)C(=O)N1C[C@H]2COC(CN2CC1)C1=CC(=C(C=C1)F)C1=CN=CO1 RIIQAEVCYNHLLI-CISYCMJJSA-N 0.000 description 2
- IUYRODVLMDVPGQ-YOEHRIQHSA-N ClC1=C(C=CC=C1OC)C(=O)N1C[C@H]2CO[C@@H](CN2CC1)C1=C(N=C(S1)C)C Chemical compound ClC1=C(C=CC=C1OC)C(=O)N1C[C@H]2CO[C@@H](CN2CC1)C1=C(N=C(S1)C)C IUYRODVLMDVPGQ-YOEHRIQHSA-N 0.000 description 2
- JPJRGNVPKJRILY-AOMKIAJQSA-N ClC1=C(C=CC=C1OC)C(=O)N1C[C@H]2CO[C@@H](CN2CC1)C1=CC(=C(C=C1)C1=CN=CO1)Cl Chemical compound ClC1=C(C=CC=C1OC)C(=O)N1C[C@H]2CO[C@@H](CN2CC1)C1=CC(=C(C=C1)C1=CN=CO1)Cl JPJRGNVPKJRILY-AOMKIAJQSA-N 0.000 description 2
- KDGCOPBVCLNDEB-GUYCJALGSA-N ClC1=C(C=CC=C1OC)C(=O)N1C[C@H]2CO[C@@H](CN2CC1)C1=NC(=CC=C1)C(F)(F)F Chemical compound ClC1=C(C=CC=C1OC)C(=O)N1C[C@H]2CO[C@@H](CN2CC1)C1=NC(=CC=C1)C(F)(F)F KDGCOPBVCLNDEB-GUYCJALGSA-N 0.000 description 2
- VCXNOPNXKUMOJY-LRDDRELGSA-N ClC1=C(C=CC=C1OC)C(=O)N1C[C@H]2CO[C@@H](CN2CC1)C=1N=NC(=CC=1)C(F)(F)F Chemical compound ClC1=C(C=CC=C1OC)C(=O)N1C[C@H]2CO[C@@H](CN2CC1)C=1N=NC(=CC=1)C(F)(F)F VCXNOPNXKUMOJY-LRDDRELGSA-N 0.000 description 2
- NHXDLNPRHRBRNE-KNVGNIICSA-N ClC=1C=C(C=CC=1F)C(CN1[C@@H](CN(CC1)C(=O)OC(C)(C)C)CO)O Chemical compound ClC=1C=C(C=CC=1F)C(CN1[C@@H](CN(CC1)C(=O)OC(C)(C)C)CO)O NHXDLNPRHRBRNE-KNVGNIICSA-N 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- MIDRYDYTVKPERL-UHFFFAOYSA-N FC(C1=C(C=NN1)C=1C=C(C(=O)O)C=CC=1)(F)F Chemical compound FC(C1=C(C=NN1)C=1C=C(C(=O)O)C=CC=1)(F)F MIDRYDYTVKPERL-UHFFFAOYSA-N 0.000 description 2
- RRPGSHHKSBIBJC-NKUHCKNESA-N FC(C=CC(C1OC[C@H](CNCC2)N2C1)=C1)=C1Br Chemical compound FC(C=CC(C1OC[C@H](CNCC2)N2C1)=C1)=C1Br RRPGSHHKSBIBJC-NKUHCKNESA-N 0.000 description 2
- TXBOWMJZGSLCHW-UHFFFAOYSA-N FC1=C(C(=O)O)C=CC=C1C=1C=NNC=1C(F)(F)F Chemical compound FC1=C(C(=O)O)C=CC=C1C=1C=NNC=1C(F)(F)F TXBOWMJZGSLCHW-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- IVDFJHOHABJVEH-UHFFFAOYSA-N HOCMe2CMe2OH Natural products CC(C)(O)C(C)(C)O IVDFJHOHABJVEH-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 238000003820 Medium-pressure liquid chromatography Methods 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010028289 Muscle atrophy Diseases 0.000 description 2
- YSLLNEYTMYVHIH-OWJWWREXSA-N N#CC1=NC=C(C(C=CC=C2C(N(CC3)C[C@@H]4N3C[C@](C(C=C3)=CC(F)=C3F)(O)OC4)=O)=C2Cl)N1 Chemical compound N#CC1=NC=C(C(C=CC=C2C(N(CC3)C[C@@H]4N3C[C@](C(C=C3)=CC(F)=C3F)(O)OC4)=O)=C2Cl)N1 YSLLNEYTMYVHIH-OWJWWREXSA-N 0.000 description 2
- 241001274216 Naso Species 0.000 description 2
- JSMJOSRBYJTYHT-UHFFFAOYSA-N O=C(C(C=CC=C1C2=CNN=C2F)=C1Cl)N(CC1)CC2N1CC(C(C=C1)=CC=C1OC(F)F)OC2 Chemical compound O=C(C(C=CC=C1C2=CNN=C2F)=C1Cl)N(CC1)CC2N1CC(C(C=C1)=CC=C1OC(F)F)OC2 JSMJOSRBYJTYHT-UHFFFAOYSA-N 0.000 description 2
- MFSBQDPSMXDMEP-PIVQAISJSA-N O=C(C(C=CC=C1C2=CNN=C2F)=C1Cl)N(CC1)C[C@@H]2N1CC(C1=CC=C(C(F)(F)F)N=C1)OC2 Chemical compound O=C(C(C=CC=C1C2=CNN=C2F)=C1Cl)N(CC1)C[C@@H]2N1CC(C1=CC=C(C(F)(F)F)N=C1)OC2 MFSBQDPSMXDMEP-PIVQAISJSA-N 0.000 description 2
- LTLANBRHAWRFDZ-SJCJKPOMSA-N O=C(C(C=CC=C1C2=CNN=C2F)=C1Cl)N(CC1)C[C@@H]2N1C[C@@H](C1=CC=C(C(F)(F)F)N=N1)OC2 Chemical compound O=C(C(C=CC=C1C2=CNN=C2F)=C1Cl)N(CC1)C[C@@H]2N1C[C@@H](C1=CC=C(C(F)(F)F)N=N1)OC2 LTLANBRHAWRFDZ-SJCJKPOMSA-N 0.000 description 2
- IOTRMYQYBCADAR-VBKZILBWSA-N O=C(C(C=CC=C1C2=CNN=C2F)=C1Cl)N(CC1)C[C@@H]2N1C[C@H](C(C=C1)=CC(Cl)=C1F)OC2 Chemical compound O=C(C(C=CC=C1C2=CNN=C2F)=C1Cl)N(CC1)C[C@@H]2N1C[C@H](C(C=C1)=CC(Cl)=C1F)OC2 IOTRMYQYBCADAR-VBKZILBWSA-N 0.000 description 2
- PEXDXAJMDFANGY-ROLPUNSJSA-N OC(C(F)(F)F)=O.OC(C([C@H]1OC[C@H](CNCC2)N2C1)=C1)=NC=C1Cl Chemical compound OC(C(F)(F)F)=O.OC(C([C@H]1OC[C@H](CNCC2)N2C1)=C1)=NC=C1Cl PEXDXAJMDFANGY-ROLPUNSJSA-N 0.000 description 2
- ANNHPHIFEQCCCP-RBZFPXEDSA-N O[C@]1(C(C=C2)=CC(Cl)=C2F)OC[C@H](CN(CC2)C(C(C=CC=C3Br)=C3Cl)=O)N2C1 Chemical compound O[C@]1(C(C=C2)=CC(Cl)=C2F)OC[C@H](CN(CC2)C(C(C=CC=C3Br)=C3Cl)=O)N2C1 ANNHPHIFEQCCCP-RBZFPXEDSA-N 0.000 description 2
- SULXAUDMJNMALP-HJPURHCSSA-N O[C@]1(C(C=C2)=CC(Cl)=C2F)OC[C@H](CN(CC2)C(C(C=CC=C3C4=CSN=C4)=C3Cl)=O)N2C1 Chemical compound O[C@]1(C(C=C2)=CC(Cl)=C2F)OC[C@H](CN(CC2)C(C(C=CC=C3C4=CSN=C4)=C3Cl)=O)N2C1 SULXAUDMJNMALP-HJPURHCSSA-N 0.000 description 2
- ADUARNHWHWOZHA-FPTDNZKUSA-N O[C@]1(C2=CC=C(C(F)(F)F)N=C2)OC[C@H](CN(CC2)C(C(C=CC=C3C4=CNN=C4F)=C3F)=O)N2C1 Chemical compound O[C@]1(C2=CC=C(C(F)(F)F)N=C2)OC[C@H](CN(CC2)C(C(C=CC=C3C4=CNN=C4F)=C3F)=O)N2C1 ADUARNHWHWOZHA-FPTDNZKUSA-N 0.000 description 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 2
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- XNRNNGPBEPRNAR-UHFFFAOYSA-N Thromboxane B2 Natural products CCCCCC(O)C=CC1OC(O)CC(O)C1CC=CCCCC(O)=O XNRNNGPBEPRNAR-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 150000001241 acetals Chemical class 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 150000001345 alkine derivatives Chemical group 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 239000012131 assay buffer Substances 0.000 description 2
- 210000001130 astrocyte Anatomy 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- GMWFCJXSQQHBPI-UHFFFAOYSA-N azetidin-3-ol Chemical compound OC1CNC1 GMWFCJXSQQHBPI-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000001555 benzenes Chemical group 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000005587 bubbling Effects 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 2
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 2
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- ZOCHARZZJNPSEU-UHFFFAOYSA-N diboron Chemical compound B#B ZOCHARZZJNPSEU-UHFFFAOYSA-N 0.000 description 2
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 2
- WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 2
- MCHMXLLGCGCRLT-UHFFFAOYSA-N dipotassium;dioxido(1,2,2-trifluoroethenoxy)borane Chemical compound [K+].[K+].[O-]B([O-])OC(F)=C(F)F MCHMXLLGCGCRLT-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 150000002118 epoxides Chemical class 0.000 description 2
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 150000002222 fluorine compounds Chemical class 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 125000005283 haloketone group Chemical group 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000000336 imidazol-5-yl group Chemical group [H]N1C([H])=NC([H])=C1[*] 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 125000004498 isoxazol-4-yl group Chemical group O1N=CC(=C1)* 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 description 2
- 230000020763 muscle atrophy Effects 0.000 description 2
- 201000000585 muscular atrophy Diseases 0.000 description 2
- KVKFRMCSXWQSNT-UHFFFAOYSA-N n,n'-dimethylethane-1,2-diamine Chemical compound CNCCNC KVKFRMCSXWQSNT-UHFFFAOYSA-N 0.000 description 2
- 239000006225 natural substrate Substances 0.000 description 2
- 210000000944 nerve tissue Anatomy 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 208000021722 neuropathic pain Diseases 0.000 description 2
- 125000004304 oxazol-5-yl group Chemical group O1C=NC=C1* 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 2
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 210000001428 peripheral nervous system Anatomy 0.000 description 2
- 230000009038 pharmacological inhibition Effects 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000000770 proinflammatory effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000004007 reversed phase HPLC Methods 0.000 description 2
- 125000006413 ring segment Chemical group 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical group CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 2
- 229910000077 silane Inorganic materials 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 2
- 229910001958 silver carbonate Inorganic materials 0.000 description 2
- 239000010802 sludge Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 125000000335 thiazolyl group Chemical group 0.000 description 2
- XNRNNGPBEPRNAR-JQBLCGNGSA-N thromboxane B2 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1OC(O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O XNRNNGPBEPRNAR-JQBLCGNGSA-N 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- SEDZOYHHAIAQIW-UHFFFAOYSA-N trimethylsilyl azide Chemical compound C[Si](C)(C)N=[N+]=[N-] SEDZOYHHAIAQIW-UHFFFAOYSA-N 0.000 description 2
- CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical compound C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- HJOAXCLZLHDZDX-UHFFFAOYSA-N tris(1,2,2-trifluoroethenyl) borate Chemical compound FC(F)=C(F)OB(OC(F)=C(F)F)OC(F)=C(F)F HJOAXCLZLHDZDX-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- ROEQGIFOWRQYHD-UHFFFAOYSA-N (2-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC=C1B(O)O ROEQGIFOWRQYHD-UHFFFAOYSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- BMQDAIUNAGXSKR-UHFFFAOYSA-N (3-hydroxy-2,3-dimethylbutan-2-yl)oxyboronic acid Chemical compound CC(C)(O)C(C)(C)OB(O)O BMQDAIUNAGXSKR-UHFFFAOYSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical group CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- ASXFMIDIRZPCGK-UHFFFAOYSA-N (4-methylpyridin-3-yl)boronic acid Chemical compound CC1=CC=NC=C1B(O)O ASXFMIDIRZPCGK-UHFFFAOYSA-N 0.000 description 1
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
- ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical compound CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- UJPMYEOUBPIPHQ-UHFFFAOYSA-N 1,1,1-trifluoroethane Chemical compound CC(F)(F)F UJPMYEOUBPIPHQ-UHFFFAOYSA-N 0.000 description 1
- ZWNWCROZSHWHSF-UHFFFAOYSA-N 1,3,4,6,7,8,9,9a-octahydropyrazino[2,1-c][1,4]oxazine Chemical compound C1COCC2CNCCN21 ZWNWCROZSHWHSF-UHFFFAOYSA-N 0.000 description 1
- RZMOICJDRADLCT-UHFFFAOYSA-N 1,4-Dibromodiacetyl Chemical compound BrCC(=O)C(=O)CBr RZMOICJDRADLCT-UHFFFAOYSA-N 0.000 description 1
- AYWGYNKWZWBMSV-UHFFFAOYSA-N 1-(1,3-benzothiazol-2-yl)-2-bromoethanone Chemical compound C1=CC=C2SC(C(=O)CBr)=NC2=C1 AYWGYNKWZWBMSV-UHFFFAOYSA-N 0.000 description 1
- WUDLRXMKBSHPAJ-UHFFFAOYSA-N 1-(1h-benzimidazol-2-yl)-2-chloroethanone Chemical compound C1=CC=C2NC(C(=O)CCl)=NC2=C1 WUDLRXMKBSHPAJ-UHFFFAOYSA-N 0.000 description 1
- XNQYDIUKOZQSOM-UHFFFAOYSA-N 1-(3-bromo-2-chlorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(Br)=C1Cl XNQYDIUKOZQSOM-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical group C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- SYQIWVMFOAHDMK-UHFFFAOYSA-N 2,2,3,3-tetramethyloxirane Chemical compound CC1(C)OC1(C)C SYQIWVMFOAHDMK-UHFFFAOYSA-N 0.000 description 1
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- MLHLHPRWRPZIKA-UHFFFAOYSA-N 2,4-dibromo-5-chloropyridine Chemical compound ClC1=CN=C(Br)C=C1Br MLHLHPRWRPZIKA-UHFFFAOYSA-N 0.000 description 1
- SSHXHQFEKOXQKM-UHFFFAOYSA-N 2,5-dichloro-4-(difluoromethyl)pyridine Chemical compound FC(F)C1=CC(Cl)=NC=C1Cl SSHXHQFEKOXQKM-UHFFFAOYSA-N 0.000 description 1
- GFTRYJQAASFSIB-UHFFFAOYSA-N 2,5-dichloro-4-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC(Cl)=NC=C1Cl GFTRYJQAASFSIB-UHFFFAOYSA-N 0.000 description 1
- KGQACOJSDXKHTB-UHFFFAOYSA-N 2,5-dichloro-4-methylpyridine Chemical compound CC1=CC(Cl)=NC=C1Cl KGQACOJSDXKHTB-UHFFFAOYSA-N 0.000 description 1
- UWKQJZCTQGMHKD-UHFFFAOYSA-N 2,6-di-tert-butylpyridine Chemical compound CC(C)(C)C1=CC=CC(C(C)(C)C)=N1 UWKQJZCTQGMHKD-UHFFFAOYSA-N 0.000 description 1
- JYWKEVKEKOTYEX-UHFFFAOYSA-N 2,6-dibromo-4-chloroiminocyclohexa-2,5-dien-1-one Chemical compound ClN=C1C=C(Br)C(=O)C(Br)=C1 JYWKEVKEKOTYEX-UHFFFAOYSA-N 0.000 description 1
- KGZGYLSAJXQGND-UHFFFAOYSA-N 2-(3-bromo-4-fluorophenyl)oxirane Chemical compound C1=C(Br)C(F)=CC=C1C1OC1 KGZGYLSAJXQGND-UHFFFAOYSA-N 0.000 description 1
- VUAQOERANOXMJB-UHFFFAOYSA-N 2-(3-chloro-4-fluorophenyl)oxirane Chemical compound C1=C(Cl)C(F)=CC=C1C1OC1 VUAQOERANOXMJB-UHFFFAOYSA-N 0.000 description 1
- IZPGJRZFAMWZTP-UHFFFAOYSA-N 2-(oxiran-2-yl)-6-(trifluoromethyl)pyridine Chemical group O1C(C1)C1=NC(=CC=C1)C(F)(F)F IZPGJRZFAMWZTP-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- YHBKLEUDZYYCSG-UHFFFAOYSA-N 2-[4-(difluoromethyl)phenyl]oxirane Chemical compound FC(F)c1ccc(cc1)C1CO1 YHBKLEUDZYYCSG-UHFFFAOYSA-N 0.000 description 1
- VVCMGAUPZIKYTH-VGHSCWAPSA-N 2-acetyloxybenzoic acid;[(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;1,3,7-trimethylpurine-2,6-dione Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VVCMGAUPZIKYTH-VGHSCWAPSA-N 0.000 description 1
- KHFRWYRANOMZCP-UHFFFAOYSA-N 2-bromo-1-(1-methylbenzimidazol-2-yl)ethanone Chemical compound C1=CC=C2N(C)C(C(=O)CBr)=NC2=C1 KHFRWYRANOMZCP-UHFFFAOYSA-N 0.000 description 1
- PLUIFJAYRBVUDM-UHFFFAOYSA-N 2-bromo-1-(2,4-dimethyl-1,3-thiazol-5-yl)ethanone Chemical compound CC1=NC(C)=C(C(=O)CBr)S1 PLUIFJAYRBVUDM-UHFFFAOYSA-N 0.000 description 1
- PAKFHEFMTRCFAU-UHFFFAOYSA-N 2-bromo-1-(3,4-dichlorophenyl)ethanone Chemical compound ClC1=CC=C(C(=O)CBr)C=C1Cl PAKFHEFMTRCFAU-UHFFFAOYSA-N 0.000 description 1
- BYIVWTZVICGYFS-UHFFFAOYSA-N 2-bromo-1-(3,4-difluorophenyl)ethanone Chemical compound FC1=CC=C(C(=O)CBr)C=C1F BYIVWTZVICGYFS-UHFFFAOYSA-N 0.000 description 1
- IBQWUOVRWLPTKR-UHFFFAOYSA-N 2-bromo-1-(4-bromo-3-chlorophenyl)ethanone Chemical compound ClC1=CC(C(=O)CBr)=CC=C1Br IBQWUOVRWLPTKR-UHFFFAOYSA-N 0.000 description 1
- HLTZXARVZDCGTL-UHFFFAOYSA-N 2-bromo-4,5-dichloropyridine Chemical compound ClC1=CN=C(Br)C=C1Cl HLTZXARVZDCGTL-UHFFFAOYSA-N 0.000 description 1
- RVPRYFUMJFTNFS-UHFFFAOYSA-N 2-chloro-1-[5-(trifluoromethyl)pyridin-2-yl]ethanone Chemical compound FC(F)(F)C1=CC=C(C(=O)CCl)N=C1 RVPRYFUMJFTNFS-UHFFFAOYSA-N 0.000 description 1
- YSEIYOHXERRMNN-UHFFFAOYSA-N 2-chloro-3,4-dimethoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C(Cl)=C1OC YSEIYOHXERRMNN-UHFFFAOYSA-N 0.000 description 1
- GUZGFKPRZFYJJT-UHFFFAOYSA-N 2-chloro-3-(1H-pyrazol-4-yl)benzoic acid Chemical compound ClC1=C(C(=O)O)C=CC=C1C=1C=NNC=1 GUZGFKPRZFYJJT-UHFFFAOYSA-N 0.000 description 1
- OCKCFQDAKCYNIB-UHFFFAOYSA-N 2-chloro-3-(2-oxo-3H-1,3-oxazol-5-yl)benzoic acid Chemical compound ClC1=C(C(=O)O)C=CC=C1C1=CNC(O1)=O OCKCFQDAKCYNIB-UHFFFAOYSA-N 0.000 description 1
- HTBJSCBVHOIOQK-UHFFFAOYSA-N 2-chloro-3-(3-methyl-1,2-oxazol-4-yl)benzoic acid Chemical compound ClC1=C(C(=O)O)C=CC=C1C=1C(=NOC=1)C HTBJSCBVHOIOQK-UHFFFAOYSA-N 0.000 description 1
- GFUVPIWFXJTGHZ-UHFFFAOYSA-N 2-chloro-3-(3-methylpyridin-2-yl)benzoic acid Chemical compound ClC1=C(C(=O)O)C=CC=C1C1=NC=CC=C1C GFUVPIWFXJTGHZ-UHFFFAOYSA-N 0.000 description 1
- YQZOPWWPJRZFAI-UHFFFAOYSA-N 2-chloro-3-(3-methylpyridin-4-yl)benzoic acid Chemical compound ClC1=C(C(=O)O)C=CC=C1C1=C(C=NC=C1)C YQZOPWWPJRZFAI-UHFFFAOYSA-N 0.000 description 1
- CDPCYTCCYJUIHO-UHFFFAOYSA-N 2-chloro-3-(4-fluoro-1H-pyrazol-5-yl)benzoic acid Chemical compound ClC1=C(C(=O)O)C=CC=C1C1=C(C=NN1)F CDPCYTCCYJUIHO-UHFFFAOYSA-N 0.000 description 1
- AEPOBVUYXMNTBU-UHFFFAOYSA-N 2-chloro-3-(4-methylpyridazin-3-yl)benzoic acid Chemical compound ClC1=C(C(=O)O)C=CC=C1C=1N=NC=CC=1C AEPOBVUYXMNTBU-UHFFFAOYSA-N 0.000 description 1
- VKSJQYYJMTWXMM-UHFFFAOYSA-N 2-chloro-3-(4-methylpyridin-3-yl)benzoic acid Chemical compound ClC1=C(C(=O)O)C=CC=C1C=1C=NC=CC=1C VKSJQYYJMTWXMM-UHFFFAOYSA-N 0.000 description 1
- MTTOBSSNAOCVDB-UHFFFAOYSA-N 2-chloro-3-(5-methylpyrimidin-4-yl)benzoic acid Chemical compound ClC1=C(C(=O)O)C=CC=C1C1=NC=NC=C1C MTTOBSSNAOCVDB-UHFFFAOYSA-N 0.000 description 1
- NBNDKLCOTZKNNJ-UHFFFAOYSA-N 2-chloro-3-(5-phenylmethoxypyridazin-4-yl)benzoic acid Chemical compound C(C1=CC=CC=C1)OC=1C(=CN=NC=1)C=1C(=C(C(=O)O)C=CC=1)Cl NBNDKLCOTZKNNJ-UHFFFAOYSA-N 0.000 description 1
- XKLMLKSXPIITAL-UHFFFAOYSA-N 2-chloro-3-methoxybenzaldehyde Chemical compound COC1=CC=CC(C=O)=C1Cl XKLMLKSXPIITAL-UHFFFAOYSA-N 0.000 description 1
- NTXFRMUTOYEXTM-UHFFFAOYSA-N 2-chloro-3-pyridazin-3-ylbenzoic acid Chemical compound ClC1=C(C(=O)O)C=CC=C1C=1N=NC=CC=1 NTXFRMUTOYEXTM-UHFFFAOYSA-N 0.000 description 1
- CODPXLKAGINSFU-UHFFFAOYSA-N 2-chloro-3-pyridazin-4-ylbenzoic acid Chemical compound ClC1=C(C(=O)O)C=CC=C1C1=CN=NC=C1 CODPXLKAGINSFU-UHFFFAOYSA-N 0.000 description 1
- VUJQAJGWJVOALQ-UHFFFAOYSA-N 2-chloro-3-pyridin-2-ylbenzoic acid Chemical compound ClC1=C(C(=O)O)C=CC=C1C1=NC=CC=C1 VUJQAJGWJVOALQ-UHFFFAOYSA-N 0.000 description 1
- FDLBKOZVASUZBU-UHFFFAOYSA-N 2-chloro-4-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=NC(Cl)=C1 FDLBKOZVASUZBU-UHFFFAOYSA-N 0.000 description 1
- RKCGJVGMRPKPNY-UHFFFAOYSA-N 2-chloro-4-fluoro-1-methoxybenzene Chemical compound COC1=CC=C(F)C=C1Cl RKCGJVGMRPKPNY-UHFFFAOYSA-N 0.000 description 1
- GXZPQJMGBKTEGG-UHFFFAOYSA-N 2-chloro-5-fluoro-4-(trifluoromethyl)pyridine Chemical compound FC1=CN=C(Cl)C=C1C(F)(F)F GXZPQJMGBKTEGG-UHFFFAOYSA-N 0.000 description 1
- HKWFZYMXXRDKIT-UHFFFAOYSA-N 2-cyano-3-methylbenzoic acid Chemical compound CC1=CC=CC(C(O)=O)=C1C#N HKWFZYMXXRDKIT-UHFFFAOYSA-N 0.000 description 1
- VUFVRYWIHCPNGN-UHFFFAOYSA-N 2-fluoro-3-(trifluoromethoxy)benzoic acid Chemical compound OC(=O)C1=CC=CC(OC(F)(F)F)=C1F VUFVRYWIHCPNGN-UHFFFAOYSA-N 0.000 description 1
- AVGWCJLTQZQLCN-UHFFFAOYSA-N 2-fluoro-3-methoxybenzoic acid Chemical compound COC1=CC=CC(C(O)=O)=C1F AVGWCJLTQZQLCN-UHFFFAOYSA-N 0.000 description 1
- HPJALMWOZYIZGE-UHFFFAOYSA-N 2-oxa-6-azaspiro[3.3]heptane Chemical compound C1NCC11COC1 HPJALMWOZYIZGE-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- WDFIJOQQKFWJEA-UHFFFAOYSA-N 3,6-dichloro-2-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=NC(Cl)=CC=C1Cl WDFIJOQQKFWJEA-UHFFFAOYSA-N 0.000 description 1
- JBDVNLVUQYVNNX-UHFFFAOYSA-N 3-(oxiran-2-yl)-6-(trifluoromethyl)pyridazine Chemical compound O1C(C1)C=1N=NC(=CC=1)C(F)(F)F JBDVNLVUQYVNNX-UHFFFAOYSA-N 0.000 description 1
- JIBWIASMUZFFST-UHFFFAOYSA-N 3-[2-(3-bromo-2-chlorophenyl)-2-oxoethyl]-1,3-thiazolidine-2,4-dione Chemical compound BrC=1C(=C(C=CC=1)C(CN1C(SCC1=O)=O)=O)Cl JIBWIASMUZFFST-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- FLPXIUQQJTXVBH-UHFFFAOYSA-N 3-bromo-2-chlorobenzamide Chemical compound NC(=O)C1=CC=CC(Br)=C1Cl FLPXIUQQJTXVBH-UHFFFAOYSA-N 0.000 description 1
- LNPUJUBLIZLHQE-UHFFFAOYSA-N 3-bromo-2-methoxy-6-(trifluoromethyl)pyridine Chemical compound COC1=NC(C(F)(F)F)=CC=C1Br LNPUJUBLIZLHQE-UHFFFAOYSA-N 0.000 description 1
- IPCVJZRBMDESEV-UHFFFAOYSA-N 3-bromo-5-chloro-1h-pyridin-2-one Chemical compound ClC1=CNC(=O)C(Br)=C1 IPCVJZRBMDESEV-UHFFFAOYSA-N 0.000 description 1
- VWNXCCTWVAQAPL-UHFFFAOYSA-N 3-bromo-6-methoxy-2-methylpyridine Chemical compound COC1=CC=C(Br)C(C)=N1 VWNXCCTWVAQAPL-UHFFFAOYSA-N 0.000 description 1
- OVUMANJVALKLBF-UHFFFAOYSA-N 3-chloro-2-fluoro-5-(oxiran-2-yl)benzonitrile Chemical compound ClC=1C(=C(C#N)C=C(C=1)C1OC1)F OVUMANJVALKLBF-UHFFFAOYSA-N 0.000 description 1
- JUCXIWZFENGFJP-UHFFFAOYSA-N 3-chloro-4-methylpyridazine Chemical compound CC1=CC=NN=C1Cl JUCXIWZFENGFJP-UHFFFAOYSA-N 0.000 description 1
- KHWJFKNWBBZMJO-UHFFFAOYSA-N 3-chloro-5-(oxiran-2-yl)pyridine Chemical compound ClC=1C=NC=C(C=1)C1OC1 KHWJFKNWBBZMJO-UHFFFAOYSA-N 0.000 description 1
- AZNKQIFEMQHORS-UHFFFAOYSA-N 3-chloro-6-(trifluoromethyl)pyridazine Chemical compound FC(F)(F)C1=CC=C(Cl)N=N1 AZNKQIFEMQHORS-UHFFFAOYSA-N 0.000 description 1
- VYNOESFHQDZAMP-UHFFFAOYSA-N 3-chloropyridazine;hydrochloride Chemical compound Cl.ClC1=CC=CN=N1 VYNOESFHQDZAMP-UHFFFAOYSA-N 0.000 description 1
- KCHQXPGUJBVNTN-UHFFFAOYSA-N 4,4-diphenylbut-3-en-2-one Chemical compound C=1C=CC=CC=1C(=CC(=O)C)C1=CC=CC=C1 KCHQXPGUJBVNTN-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- WVGCPEDBFHEHEZ-UHFFFAOYSA-N 4-bromo-1h-pyrazole Chemical compound BrC=1C=NNC=1 WVGCPEDBFHEHEZ-UHFFFAOYSA-N 0.000 description 1
- ZXVFKQRZKKGVNJ-UHFFFAOYSA-N 4-bromo-1h-pyrazole-5-carbonitrile Chemical compound BrC=1C=NNC=1C#N ZXVFKQRZKKGVNJ-UHFFFAOYSA-N 0.000 description 1
- SSLMGOKTIUIZLY-UHFFFAOYSA-N 4-bromo-1h-pyridin-2-one Chemical compound OC1=CC(Br)=CC=N1 SSLMGOKTIUIZLY-UHFFFAOYSA-N 0.000 description 1
- PKPXCBIUESSICA-UHFFFAOYSA-N 4-bromo-2-chloro-n,n-dimethylaniline Chemical compound CN(C)C1=CC=C(Br)C=C1Cl PKPXCBIUESSICA-UHFFFAOYSA-N 0.000 description 1
- JTHNMRUVJDWVMJ-UHFFFAOYSA-N 4-bromo-5-(trifluoromethyl)-1h-pyrazole Chemical compound FC(F)(F)C=1NN=CC=1Br JTHNMRUVJDWVMJ-UHFFFAOYSA-N 0.000 description 1
- RXVJMXCAYIZVKM-UHFFFAOYSA-N 4-bromo-6-methyl-1h-pyridin-2-one Chemical compound CC1=CC(Br)=CC(=O)N1 RXVJMXCAYIZVKM-UHFFFAOYSA-N 0.000 description 1
- MVAXCERVDARFPE-UHFFFAOYSA-N 4-chloro-2-(oxiran-2-yl)pyridine Chemical compound ClC1=CC=NC(C2OC2)=C1 MVAXCERVDARFPE-UHFFFAOYSA-N 0.000 description 1
- RPDVPWWBNQKLAS-UHFFFAOYSA-N 4-chloro-5-methylpyrimidine Chemical compound CC1=CN=CN=C1Cl RPDVPWWBNQKLAS-UHFFFAOYSA-N 0.000 description 1
- HJSCQRDGGJZGJH-UHFFFAOYSA-N 4-chloroquinoline-3-carboxylic acid Chemical compound C1=CC=CC2=C(Cl)C(C(=O)O)=CN=C21 HJSCQRDGGJZGJH-UHFFFAOYSA-N 0.000 description 1
- SRFCCWMMWYCDSK-UHFFFAOYSA-N 4-chlorothieno[2,3-b]pyridine-5-carboxylic acid Chemical compound OC(=O)C1=CN=C2SC=CC2=C1Cl SRFCCWMMWYCDSK-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- DTGDMPJDZKDHEP-UHFFFAOYSA-N 4-ethenylbicyclo[4.2.0]octa-1(6),2,4-triene Chemical compound C=CC1=CC=C2CCC2=C1 DTGDMPJDZKDHEP-UHFFFAOYSA-N 0.000 description 1
- RJEUKZIJMOUZGF-UHFFFAOYSA-N 5-(1,3,4,6,7,8,9,9a-octahydropyrazino[2,1-c][1,4]oxazin-3-yl)-2-fluorobenzonitrile Chemical compound C1=C(C#N)C(F)=CC=C1C1OCC2CNCCN2C1 RJEUKZIJMOUZGF-UHFFFAOYSA-N 0.000 description 1
- LINPUNQBDMRCNN-UHFFFAOYSA-N 5-(3-bromo-2-chlorophenyl)-3H-1,3,4-oxadiazol-2-one Chemical compound Clc1c(Br)cccc1-c1n[nH]c(=O)o1 LINPUNQBDMRCNN-UHFFFAOYSA-N 0.000 description 1
- DXZFZIQXGDJVCL-UHFFFAOYSA-N 5-bromo-1h-imidazole-2-carbonitrile Chemical compound BrC1=CNC(C#N)=N1 DXZFZIQXGDJVCL-UHFFFAOYSA-N 0.000 description 1
- NDMZZQRNZFWMEZ-UHFFFAOYSA-N 5-bromo-1h-pyridin-2-one Chemical compound OC1=CC=C(Br)C=N1 NDMZZQRNZFWMEZ-UHFFFAOYSA-N 0.000 description 1
- GYCNHFWRPJXTSB-UHFFFAOYSA-N 5-bromo-2-fluorobenzonitrile Chemical compound FC1=CC=C(Br)C=C1C#N GYCNHFWRPJXTSB-UHFFFAOYSA-N 0.000 description 1
- GQHRGRHDKCJTKG-UHFFFAOYSA-N 5-bromo-4-fluoro-1h-pyrazole Chemical compound FC=1C=NNC=1Br GQHRGRHDKCJTKG-UHFFFAOYSA-N 0.000 description 1
- GJPQSWZLTVFMDU-UHFFFAOYSA-N 5-chloro-1h-pyridazin-4-one Chemical compound ClC1=CNN=CC1=O GJPQSWZLTVFMDU-UHFFFAOYSA-N 0.000 description 1
- JZMSYGWMHMYTAR-UHFFFAOYSA-N 5-chloro-2-(oxiran-2-yl)-4-(trifluoromethyl)pyridine Chemical compound ClC=1C(=CC(=NC=1)C1OC1)C(F)(F)F JZMSYGWMHMYTAR-UHFFFAOYSA-N 0.000 description 1
- OSCXQIGRXPXMOO-UHFFFAOYSA-N 5-chloro-3-ethenyl-2-phenylmethoxypyridine Chemical compound C(C1=CC=CC=C1)OC1=NC=C(C=C1C=C)Cl OSCXQIGRXPXMOO-UHFFFAOYSA-N 0.000 description 1
- OLACXEWAQCEAIS-UHFFFAOYSA-N 5-chloro-4-methyl-2-(oxiran-2-yl)pyridine Chemical compound ClC=1C(=CC(=NC=1)C1OC1)C OLACXEWAQCEAIS-UHFFFAOYSA-N 0.000 description 1
- KNZFCCPCUDUDKL-UHFFFAOYSA-N 5-fluoro-2-(oxiran-2-yl)-4-(trifluoromethyl)pyridine Chemical compound FC=1C(=CC(=NC=1)C1OC1)C(F)(F)F KNZFCCPCUDUDKL-UHFFFAOYSA-N 0.000 description 1
- BHCMXJKPZOPRNN-UHFFFAOYSA-N 5-iodo-1h-imidazole Chemical compound IC1=CN=CN1 BHCMXJKPZOPRNN-UHFFFAOYSA-N 0.000 description 1
- LEIFRCSFCUIXIW-UHFFFAOYSA-N 6-methoxypyridine-2-carbothioamide Chemical compound COC1=CC=CC(C(N)=S)=N1 LEIFRCSFCUIXIW-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 description 1
- 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- KGLMVGXSOIOVDW-UGSOOPFHSA-N BrC=1C(=C(C=C(C=1)F)C(=O)N1C[C@H]2CO[C@@H](CN2CC1)C1=CC(=C(C=C1)F)Cl)Cl Chemical compound BrC=1C(=C(C=C(C=1)F)C(=O)N1C[C@H]2CO[C@@H](CN2CC1)C1=CC(=C(C=C1)F)Cl)Cl KGLMVGXSOIOVDW-UGSOOPFHSA-N 0.000 description 1
- ZJZMLTCCGVIEHB-UHFFFAOYSA-N BrCC(=O)C=1N=C(SC=1)C=1C=NC(=CC=1)OC Chemical compound BrCC(=O)C=1N=C(SC=1)C=1C=NC(=CC=1)OC ZJZMLTCCGVIEHB-UHFFFAOYSA-N 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 238000006443 Buchwald-Hartwig cross coupling reaction Methods 0.000 description 1
- MIILPKJQGAEVEQ-JEDNCBNOSA-N C(=O)OC(C)(C)C.OC[C@@H]1CNCCN1 Chemical compound C(=O)OC(C)(C)C.OC[C@@H]1CNCCN1 MIILPKJQGAEVEQ-JEDNCBNOSA-N 0.000 description 1
- NJSCJKVJFOMWPP-HWKANZROSA-N C/C=C/C(C=C(C1OCC(CN(CC2)C(C(C=CC=C3OC)=C3Cl)=O)N2C1)C=C1)=C1F Chemical compound C/C=C/C(C=C(C1OCC(CN(CC2)C(C(C=CC=C3OC)=C3Cl)=O)N2C1)C=C1)=C1F NJSCJKVJFOMWPP-HWKANZROSA-N 0.000 description 1
- PCJFJOOWIKWJOC-UGSOOPFHSA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=C(C(=CC=C4)OC(F)(F)F)F Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=C(C(=CC=C4)OC(F)(F)F)F PCJFJOOWIKWJOC-UGSOOPFHSA-N 0.000 description 1
- OEXWDNAHUBZTME-UGSOOPFHSA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=C(C(=CC=C4)OC(F)F)Cl Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=C(C(=CC=C4)OC(F)F)Cl OEXWDNAHUBZTME-UGSOOPFHSA-N 0.000 description 1
- PVXKPERJLMEJRH-BTYIYWSLSA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=C(C5=CC=CC=C5N=C4)Cl Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=C(C5=CC=CC=C5N=C4)Cl PVXKPERJLMEJRH-BTYIYWSLSA-N 0.000 description 1
- PTTJBHNLHLBKTH-CYFREDJKSA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CC=CC=C5 Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=CC=CC=C5 PTTJBHNLHLBKTH-CYFREDJKSA-N 0.000 description 1
- CJHIMZGDRYAKKF-UGSOOPFHSA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CN=C5C(=C4Cl)C=CS5 Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CN=C5C(=C4Cl)C=CS5 CJHIMZGDRYAKKF-UGSOOPFHSA-N 0.000 description 1
- JKTGPJQDRMEZMA-SJCJKPOMSA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CN=C5C(=C4Cl)C=NN5 Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CN=C5C(=C4Cl)C=NN5 JKTGPJQDRMEZMA-SJCJKPOMSA-N 0.000 description 1
- SXVPHUYDOPDTDA-KKSFZXQISA-N C1CN(C[C@@H]2N1C[C@H](OC2)C3=CNC(=CC3=O)C(F)(F)F)C(=O)C4=CC(=CC(=C4Cl)C5=CNC(=C5)C#N)F Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CNC(=CC3=O)C(F)(F)F)C(=O)C4=CC(=CC(=C4Cl)C5=CNC(=C5)C#N)F SXVPHUYDOPDTDA-KKSFZXQISA-N 0.000 description 1
- JSMJOSRBYJTYHT-OOJLDXBWSA-N C1CN2CC(OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=C(NN=C4)F)C5=CC=C(C=C5)OC(F)F Chemical compound C1CN2CC(OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=C(NN=C4)F)C5=CC=C(C=C5)OC(F)F JSMJOSRBYJTYHT-OOJLDXBWSA-N 0.000 description 1
- ZASDNDJCOUMKTK-WNSKOXEYSA-N C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=CN=CO4)(C5=CC(=C(C=C5)F)Cl)O Chemical compound C1CN2C[C@](OC[C@@H]2CN1C(=O)C3=CC=CC(=C3Cl)C4=CN=CO4)(C5=CC(=C(C=C5)F)Cl)O ZASDNDJCOUMKTK-WNSKOXEYSA-N 0.000 description 1
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 description 1
- 102000009132 CB1 Cannabinoid Receptor Human genes 0.000 description 1
- 108010073366 CB1 Cannabinoid Receptor Proteins 0.000 description 1
- 102000009135 CB2 Cannabinoid Receptor Human genes 0.000 description 1
- 108010073376 CB2 Cannabinoid Receptor Proteins 0.000 description 1
- KDZAPYQCTCMOGG-HXBUSHRASA-N CC#CC(C=C(C1OC[C@H](CN(CC2)C(C(C=CC=C3OC)=C3Cl)=O)N2C1)C=C1)=C1F Chemical compound CC#CC(C=C(C1OC[C@H](CN(CC2)C(C(C=CC=C3OC)=C3Cl)=O)N2C1)C=C1)=C1F KDZAPYQCTCMOGG-HXBUSHRASA-N 0.000 description 1
- JVAIGDKSUPWSDC-UHFFFAOYSA-N CC(C)(C)OC(N(CC1)CC2N1CC(C(C=C1)=CC(Cl)=C1F)OC2)=O Chemical compound CC(C)(C)OC(N(CC1)CC2N1CC(C(C=C1)=CC(Cl)=C1F)OC2)=O JVAIGDKSUPWSDC-UHFFFAOYSA-N 0.000 description 1
- QZFXLIFQIVDRTO-FQNRMIAFSA-N CC(C)(C)OC(N(CC1)CC2N1C[C@H](C(C=C1)=CC(Br)=C1F)OC2)=O Chemical compound CC(C)(C)OC(N(CC1)CC2N1C[C@H](C(C=C1)=CC(Br)=C1F)OC2)=O QZFXLIFQIVDRTO-FQNRMIAFSA-N 0.000 description 1
- PKCGUZKTFNSKOH-CFMCSPIPSA-N CC(C)(C)OC(N(CC1)C[C@@H]2N1CC(C(C=C1)=NC=C1Br)OC2)=O Chemical compound CC(C)(C)OC(N(CC1)C[C@@H]2N1CC(C(C=C1)=NC=C1Br)OC2)=O PKCGUZKTFNSKOH-CFMCSPIPSA-N 0.000 description 1
- VJAWJYNUGFORAY-GTNSWQLSSA-N CC(C)(C)OC(N(CC1)C[C@@H]2N1C[C@](C1=CC=C(C(F)(F)F)NC1=O)(O)OC2)=O Chemical compound CC(C)(C)OC(N(CC1)C[C@@H]2N1C[C@](C1=CC=C(C(F)(F)F)NC1=O)(O)OC2)=O VJAWJYNUGFORAY-GTNSWQLSSA-N 0.000 description 1
- FUUXHNVWMKJWAS-UHFFFAOYSA-N CC(N1)=CC(C2=CC=CC(C(O)=O)=C2Cl)=CC1=O Chemical compound CC(N1)=CC(C2=CC=CC(C(O)=O)=C2Cl)=CC1=O FUUXHNVWMKJWAS-UHFFFAOYSA-N 0.000 description 1
- FCPIRTGMUCEHJU-UHFFFAOYSA-N CC(NC(C=C1)=O)=C1C1=CC=CC(C(O)=O)=C1Cl Chemical compound CC(NC(C=C1)=O)=C1C1=CC=CC(C(O)=O)=C1Cl FCPIRTGMUCEHJU-UHFFFAOYSA-N 0.000 description 1
- XPWMTIQUMMXWFM-UUOWRZLLSA-N CC1=C(C=CN=C1)C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl Chemical compound CC1=C(C=CN=C1)C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl XPWMTIQUMMXWFM-UUOWRZLLSA-N 0.000 description 1
- LRQYIECSZJAQIU-JTSKRJEESA-N CC1=C(N=NC=C1)C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl Chemical compound CC1=C(N=NC=C1)C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl LRQYIECSZJAQIU-JTSKRJEESA-N 0.000 description 1
- IUYRODVLMDVPGQ-RHSMWYFYSA-N CC1=C(SC(=N1)C)[C@H]2CN3CCN(C[C@@H]3CO2)C(=O)C4=C(C(=CC=C4)OC)Cl Chemical compound CC1=C(SC(=N1)C)[C@H]2CN3CCN(C[C@@H]3CO2)C(=O)C4=C(C(=CC=C4)OC)Cl IUYRODVLMDVPGQ-RHSMWYFYSA-N 0.000 description 1
- IUYRODVLMDVPGQ-PBHICJAKSA-N CC1=C([C@H]2OC[C@@H](CN(CC3)C(C(C=CC=C4OC)=C4Cl)=O)N3C2)SC(C)=N1 Chemical compound CC1=C([C@H]2OC[C@@H](CN(CC3)C(C(C=CC=C4OC)=C4Cl)=O)N3C2)SC(C)=N1 IUYRODVLMDVPGQ-PBHICJAKSA-N 0.000 description 1
- AAKABRFXRSZPPB-VBKZILBWSA-N CC1=C([C@]2(O)OC[C@H](CN(CC3)C(C(C=CC=C4OC)=C4Cl)=O)N3C2)SC(C)=N1 Chemical compound CC1=C([C@]2(O)OC[C@H](CN(CC3)C(C(C=CC=C4OC)=C4Cl)=O)N3C2)SC(C)=N1 AAKABRFXRSZPPB-VBKZILBWSA-N 0.000 description 1
- MEHZUAWYVBYPRK-LIRRHRJNSA-N CC1=C2C(=NN1)C=CC(=C2Cl)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl Chemical compound CC1=C2C(=NN1)C=CC(=C2Cl)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl MEHZUAWYVBYPRK-LIRRHRJNSA-N 0.000 description 1
- CRDXEGYYSJXTST-JTSKRJEESA-N CC1=CN=CN=C1C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl Chemical compound CC1=CN=CN=C1C2=C(C(=CC=C2)C(=O)N3CCN4C[C@H](OC[C@@H]4C3)C5=CC(=C(C=C5)F)Cl)Cl CRDXEGYYSJXTST-JTSKRJEESA-N 0.000 description 1
- JOOPMAIXRHZWNX-XOBRGWDASA-N COC(C=C1OC)=CC(C(N(CC2)C[C@@H]3N2C[C@@H](C(C=C2)=CC(Cl)=C2F)OC3)=O)=C1Cl Chemical compound COC(C=C1OC)=CC(C(N(CC2)C[C@@H]3N2C[C@@H](C(C=C2)=CC(Cl)=C2F)OC3)=O)=C1Cl JOOPMAIXRHZWNX-XOBRGWDASA-N 0.000 description 1
- SGFDDSXAMCZSGF-UHFFFAOYSA-N COC(C=CC=C1)=C1C(C=CC=C1C(O)=O)=C1Cl Chemical compound COC(C=CC=C1)=C1C(C=CC=C1C(O)=O)=C1Cl SGFDDSXAMCZSGF-UHFFFAOYSA-N 0.000 description 1
- FPBQCULDIREQCO-SCLBCKFNSA-N COC1=C(C(=C(C=C1)F)C(=O)N2CCN3C[C@@H](OC[C@@H]3C2)C4=CC(=C(C=C4)F)Cl)Cl Chemical compound COC1=C(C(=C(C=C1)F)C(=O)N2CCN3C[C@@H](OC[C@@H]3C2)C4=CC(=C(C=C4)F)Cl)Cl FPBQCULDIREQCO-SCLBCKFNSA-N 0.000 description 1
- GXZZXVSATBQVEW-ZSEKCTLFSA-N COC1=C(C(=C(C=C1)F)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC(=C(C=C4)F)Cl)O)Cl Chemical compound COC1=C(C(=C(C=C1)F)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC(=C(C=C4)F)Cl)O)Cl GXZZXVSATBQVEW-ZSEKCTLFSA-N 0.000 description 1
- CRWZQFOURMNYNW-NBGIEHNGSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@@H](OC[C@@H]3C2)C4=CC(=C(C=C4)F)C5=CC=CC=C5 Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@@H](OC[C@@H]3C2)C4=CC(=C(C=C4)F)C5=CC=CC=C5 CRWZQFOURMNYNW-NBGIEHNGSA-N 0.000 description 1
- PZEJAVWHPMGGTC-LIRRHRJNSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=CC(=C(C=C4)Br)Cl Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=CC(=C(C=C4)Br)Cl PZEJAVWHPMGGTC-LIRRHRJNSA-N 0.000 description 1
- LVGZDMLIBFDDFZ-JXFKEZNVSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=CC(=C(C=C4)F)C#N Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=CC(=C(C=C4)F)C#N LVGZDMLIBFDDFZ-JXFKEZNVSA-N 0.000 description 1
- CRWZQFOURMNYNW-CPJSRVTESA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=CC(=C(C=C4)F)C5=CC=CC=C5 Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@H](OC[C@@H]3C2)C4=CC(=C(C=C4)F)C5=CC=CC=C5 CRWZQFOURMNYNW-CPJSRVTESA-N 0.000 description 1
- OHNLGZZNDRSETG-QKVFXAPYSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=C(C(=C(C=C4)F)F)F)O Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=C(C(=C(C=C4)F)F)F)O OHNLGZZNDRSETG-QKVFXAPYSA-N 0.000 description 1
- PIGPOEWEAWPMCR-QKKBWIMNSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=C(C=C(C=C4)Cl)Cl)O Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=C(C=C(C=C4)Cl)Cl)O PIGPOEWEAWPMCR-QKKBWIMNSA-N 0.000 description 1
- OOERBPXZQKHWBH-QKKBWIMNSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC(=C(C=C4)Cl)F)O Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC(=C(C=C4)Cl)F)O OOERBPXZQKHWBH-QKKBWIMNSA-N 0.000 description 1
- AEEBFSYPEMJKPD-KKSFZXQISA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC(=CC(=C4)Br)Cl)O Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC(=CC(=C4)Br)Cl)O AEEBFSYPEMJKPD-KKSFZXQISA-N 0.000 description 1
- LVFDOYNSDGSGSV-VOJFVSQTSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC(=NO4)Br)O Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC(=NO4)Br)O LVFDOYNSDGSGSV-VOJFVSQTSA-N 0.000 description 1
- RAPZRPLMYHFMHK-QKKBWIMNSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC=CC=C4Cl)O Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=CC=CC=C4Cl)O RAPZRPLMYHFMHK-QKKBWIMNSA-N 0.000 description 1
- XGLUSHGUCBNAQF-FPTDNZKUSA-N COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=NC5=CC=CC=C5S4)O Chemical compound COC1=CC=CC(=C1Cl)C(=O)N2CCN3C[C@](OC[C@@H]3C2)(C4=NC5=CC=CC=C5S4)O XGLUSHGUCBNAQF-FPTDNZKUSA-N 0.000 description 1
- FGXPZHROXKFGCI-UHFFFAOYSA-N COC1=CC=CC(C(N(CC2)CC3N2CC(C(C=C2)=CC(Cl)=C2F)OC3)=O)=C1Br Chemical compound COC1=CC=CC(C(N(CC2)CC3N2CC(C(C=C2)=CC(Cl)=C2F)OC3)=O)=C1Br FGXPZHROXKFGCI-UHFFFAOYSA-N 0.000 description 1
- VXXJMEFDRMETTG-UHFFFAOYSA-N COC1=CC=CC(C(N(CC2)CC3N2CC(C2=NC=CC(Cl)=C2)OC3)=O)=C1Cl Chemical compound COC1=CC=CC(C(N(CC2)CC3N2CC(C2=NC=CC(Cl)=C2)OC3)=O)=C1Cl VXXJMEFDRMETTG-UHFFFAOYSA-N 0.000 description 1
- FRMDDRBLQJCTOR-KTQQKIMGSA-N COC1=CC=CC(C(N(CC2)C[C@@H]3N2CC(C(C=C2)=CC(Br)=C2F)OC3)=O)=C1Cl Chemical compound COC1=CC=CC(C(N(CC2)C[C@@H]3N2CC(C(C=C2)=CC(Br)=C2F)OC3)=O)=C1Cl FRMDDRBLQJCTOR-KTQQKIMGSA-N 0.000 description 1
- CRWZQFOURMNYNW-JINQPTGOSA-N COC1=CC=CC(C(N(CC2)C[C@@H]3N2CC(C(C=C2)=CC(C4=CC=CC=C4)=C2F)OC3)=O)=C1Cl Chemical compound COC1=CC=CC(C(N(CC2)C[C@@H]3N2CC(C(C=C2)=CC(C4=CC=CC=C4)=C2F)OC3)=O)=C1Cl CRWZQFOURMNYNW-JINQPTGOSA-N 0.000 description 1
- PKOJSIFCMRARMJ-LBOXEOMUSA-N COC1=CC=CC(C(N(CC2)C[C@@H]3N2CC(C(C=C2)=CC(C4CC4)=C2F)OC3)=O)=C1Cl Chemical compound COC1=CC=CC(C(N(CC2)C[C@@H]3N2CC(C(C=C2)=CC(C4CC4)=C2F)OC3)=O)=C1Cl PKOJSIFCMRARMJ-LBOXEOMUSA-N 0.000 description 1
- FGXPZHROXKFGCI-KTQQKIMGSA-N COC1=CC=CC(C(N(CC2)C[C@@H]3N2CC(C(C=C2)=CC(Cl)=C2F)OC3)=O)=C1Br Chemical compound COC1=CC=CC(C(N(CC2)C[C@@H]3N2CC(C(C=C2)=CC(Cl)=C2F)OC3)=O)=C1Br FGXPZHROXKFGCI-KTQQKIMGSA-N 0.000 description 1
- DHBBVZIYBIPYIQ-SGTLLEGYSA-N COC1=CC=CC(C(N(CC2)C[C@@H]3N2C[C@@H](C(C=C2C(F)F)=NC=C2F)OC3)=O)=C1Cl Chemical compound COC1=CC=CC(C(N(CC2)C[C@@H]3N2C[C@@H](C(C=C2C(F)F)=NC=C2F)OC3)=O)=C1Cl DHBBVZIYBIPYIQ-SGTLLEGYSA-N 0.000 description 1
- NFIVJNVHTVOVPP-KKSFZXQISA-N COC1=CC=CC(C(N(CC2)C[C@@H]3N2C[C@](C2=CC=C(C(F)(F)F)C=C2)(O)OC3)=O)=C1Cl Chemical compound COC1=CC=CC(C(N(CC2)C[C@@H]3N2C[C@](C2=CC=C(C(F)(F)F)C=C2)(O)OC3)=O)=C1Cl NFIVJNVHTVOVPP-KKSFZXQISA-N 0.000 description 1
- JTYOJTGYXFTDET-UHFFFAOYSA-N COC1=CC=CC(C(N2CC(CO)N(CC(C3=CC=C(CC4)C4=C3)O)CC2)=O)=C1Cl Chemical compound COC1=CC=CC(C(N2CC(CO)N(CC(C3=CC=C(CC4)C4=C3)O)CC2)=O)=C1Cl JTYOJTGYXFTDET-UHFFFAOYSA-N 0.000 description 1
- ZUEBGRABWGVHOC-FYSMJZIKSA-N COC1=NC=C(C=C1)C2=NC(=CS2)[C@@]3(CN4CCN(C[C@H]4CO3)C(=O)C5=C(C(=CC=C5)OC)Cl)O Chemical compound COC1=NC=C(C=C1)C2=NC(=CS2)[C@@]3(CN4CCN(C[C@H]4CO3)C(=O)C5=C(C(=CC=C5)OC)Cl)O ZUEBGRABWGVHOC-FYSMJZIKSA-N 0.000 description 1
- LLCBHHNMCLINRY-UHFFFAOYSA-N COc1cc(ncc1Br)C(F)(F)F Chemical compound COc1cc(ncc1Br)C(F)(F)F LLCBHHNMCLINRY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-NJFSPNSNSA-N Carbon-14 Chemical compound [14C] OKTJSMMVPCPJKN-NJFSPNSNSA-N 0.000 description 1
- JBMKVCHDXGYDFH-UHFFFAOYSA-N Cc1[nH]nc2ccc(C(O)=O)c(Cl)c12 Chemical compound Cc1[nH]nc2ccc(C(O)=O)c(Cl)c12 JBMKVCHDXGYDFH-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- MPONAPFARZGDTH-UHFFFAOYSA-N Cl.OS(O)=O Chemical compound Cl.OS(O)=O MPONAPFARZGDTH-UHFFFAOYSA-N 0.000 description 1
- SFDVPNTZPSBHHL-GWCFXTLKSA-N ClC(C=C([C@H]1OC[C@H](CNCC2)N2C1)C=C1)=C1Br Chemical compound ClC(C=C([C@H]1OC[C@H](CNCC2)N2C1)C=C1)=C1Br SFDVPNTZPSBHHL-GWCFXTLKSA-N 0.000 description 1
- ZUZLMIJJHPVKJS-GWCFXTLKSA-N ClC(C=CC([C@H]1OC[C@H](CNCC2)N2C1)=C1)=C1Cl Chemical compound ClC(C=CC([C@H]1OC[C@H](CNCC2)N2C1)=C1)=C1Cl ZUZLMIJJHPVKJS-GWCFXTLKSA-N 0.000 description 1
- OJNGVHZBPVMXIO-UHFFFAOYSA-N ClC1=C(C(=O)O)C=C(C=C1C1=CNC(=C1)C#N)F Chemical compound ClC1=C(C(=O)O)C=C(C=C1C1=CNC(=C1)C#N)F OJNGVHZBPVMXIO-UHFFFAOYSA-N 0.000 description 1
- LINAUXDKCNXYOK-UHFFFAOYSA-N ClC1=C(C(=O)O)C=C(C=C1C=1C(=NNC=1)F)F Chemical compound ClC1=C(C(=O)O)C=C(C=C1C=1C(=NNC=1)F)F LINAUXDKCNXYOK-UHFFFAOYSA-N 0.000 description 1
- CHTBNVWXWYLMAJ-UHFFFAOYSA-N ClC1=C(C(=O)O)C=CC=C1C1=CN=C(N1)C#N Chemical compound ClC1=C(C(=O)O)C=CC=C1C1=CN=C(N1)C#N CHTBNVWXWYLMAJ-UHFFFAOYSA-N 0.000 description 1
- YBJATIOAYVQMRF-UHFFFAOYSA-N ClC1=C(C(=O)O)C=CC=C1C1=CNC(=C1)C#N Chemical compound ClC1=C(C(=O)O)C=CC=C1C1=CNC(=C1)C#N YBJATIOAYVQMRF-UHFFFAOYSA-N 0.000 description 1
- OWLGNVLJKAQNEF-UHFFFAOYSA-N ClC1=C(C(=O)O)C=CC=C1C1=NNC(=C1)C#N Chemical compound ClC1=C(C(=O)O)C=CC=C1C1=NNC(=C1)C#N OWLGNVLJKAQNEF-UHFFFAOYSA-N 0.000 description 1
- ICNPBRZGILIHAU-UHFFFAOYSA-N ClC1=C(C(=O)O)C=CC=C1C=1C(C=NNC=1)=O Chemical compound ClC1=C(C(=O)O)C=CC=C1C=1C(C=NNC=1)=O ICNPBRZGILIHAU-UHFFFAOYSA-N 0.000 description 1
- OYGGSXPVHUYWRC-UHFFFAOYSA-N ClC1=C(C(=O)O)C=CC=C1C=1C=NN(C=1C)C Chemical compound ClC1=C(C(=O)O)C=CC=C1C=1C=NN(C=1C)C OYGGSXPVHUYWRC-UHFFFAOYSA-N 0.000 description 1
- RQZAWDZTAFKXQY-UHFFFAOYSA-N ClC1=C(C(=O)O)C=CC=C1C=1C=NNC=1C Chemical compound ClC1=C(C(=O)O)C=CC=C1C=1C=NNC=1C RQZAWDZTAFKXQY-UHFFFAOYSA-N 0.000 description 1
- PDYBPTDSZDGNNT-UHFFFAOYSA-N ClC1=C(C(=O)O)C=CC=C1C=1N=CNC=1 Chemical compound ClC1=C(C(=O)O)C=CC=C1C=1N=CNC=1 PDYBPTDSZDGNNT-UHFFFAOYSA-N 0.000 description 1
- MQVGVYCJNLAFII-UHFFFAOYSA-N ClC1=C(C(=O)O)C=CC=C1C=1N=NNC=1 Chemical compound ClC1=C(C(=O)O)C=CC=C1C=1N=NNC=1 MQVGVYCJNLAFII-UHFFFAOYSA-N 0.000 description 1
- DSWSKXZOXZUYJB-UHFFFAOYSA-N ClC1=C(C(=O)O)C=CC=C1N1CC(NCC1)=O Chemical compound ClC1=C(C(=O)O)C=CC=C1N1CC(NCC1)=O DSWSKXZOXZUYJB-UHFFFAOYSA-N 0.000 description 1
- UWOXCLDPPAUTPQ-UHFFFAOYSA-N ClC1=C(C(=O)O)C=CC=C1N1CC2(COC2)C1 Chemical compound ClC1=C(C(=O)O)C=CC=C1N1CC2(COC2)C1 UWOXCLDPPAUTPQ-UHFFFAOYSA-N 0.000 description 1
- VJDJSGIIDBVDRY-UHFFFAOYSA-N ClC1=C(C(=O)OC)C=C(C=C1C1=CNC(=C1)C#N)F Chemical compound ClC1=C(C(=O)OC)C=C(C=C1C1=CNC(=C1)C#N)F VJDJSGIIDBVDRY-UHFFFAOYSA-N 0.000 description 1
- DMAUNKMQSZTEJN-UHFFFAOYSA-N ClC1=C(C(=O)OC)C=C(C=C1C=1C(=NNC=1)F)F Chemical compound ClC1=C(C(=O)OC)C=C(C=C1C=1C(=NNC=1)F)F DMAUNKMQSZTEJN-UHFFFAOYSA-N 0.000 description 1
- UXRNPOJZHIHKSD-UHFFFAOYSA-N ClC1=C(C(=O)OC)C=CC=C1C1=CN=C(N1)C#N Chemical compound ClC1=C(C(=O)OC)C=CC=C1C1=CN=C(N1)C#N UXRNPOJZHIHKSD-UHFFFAOYSA-N 0.000 description 1
- GULDPSGIMWFXMB-UHFFFAOYSA-N ClC1=C(C(=O)OC)C=CC=C1C=1C(=NNC=1)F Chemical compound ClC1=C(C(=O)OC)C=CC=C1C=1C(=NNC=1)F GULDPSGIMWFXMB-UHFFFAOYSA-N 0.000 description 1
- BGGKCAIKOBNJEB-UHFFFAOYSA-N ClC1=C(C(=O)OC)C=CC=C1N1CC(C1)O Chemical compound ClC1=C(C(=O)OC)C=CC=C1N1CC(C1)O BGGKCAIKOBNJEB-UHFFFAOYSA-N 0.000 description 1
- UNTWRDDDEXJBER-UHFFFAOYSA-N ClC1=C(C(=O)OC)C=CC=C1N1CC(NCC1)=O Chemical compound ClC1=C(C(=O)OC)C=CC=C1N1CC(NCC1)=O UNTWRDDDEXJBER-UHFFFAOYSA-N 0.000 description 1
- KMWFDBLYBXHNHG-UHFFFAOYSA-M ClC1=C(C(=O)[O-])C=CC=C1N1CC(C1)O.[Li+] Chemical compound ClC1=C(C(=O)[O-])C=CC=C1N1CC(C1)O.[Li+] KMWFDBLYBXHNHG-UHFFFAOYSA-M 0.000 description 1
- VXXJMEFDRMETTG-KSSFIOAISA-N ClC1=CC(=NC=C1)[C@@H]1CN2[C@H](CO1)CN(CC2)C(=O)C1=C(C(=CC=C1)OC)Cl Chemical compound ClC1=CC(=NC=C1)[C@@H]1CN2[C@H](CO1)CN(CC2)C(=O)C1=C(C(=CC=C1)OC)Cl VXXJMEFDRMETTG-KSSFIOAISA-N 0.000 description 1
- DLBMDUMVUKGYFC-UGSOOPFHSA-N ClC=1C=C(C(NC=1)=O)[C@@H]1CN2[C@H](CO1)CN(CC2)C(C1=C(C(=CC=C1)C1=NNC=C1F)Cl)=O Chemical compound ClC=1C=C(C(NC=1)=O)[C@@H]1CN2[C@H](CO1)CN(CC2)C(C1=C(C(=CC=C1)C1=NNC=C1F)Cl)=O DLBMDUMVUKGYFC-UGSOOPFHSA-N 0.000 description 1
- JVAIGDKSUPWSDC-BBRMVZONSA-N ClC=1C=C(C=CC=1F)[C@@H]1CN2[C@H](CO1)CN(CC2)C(=O)OC(C)(C)C Chemical compound ClC=1C=C(C=CC=1F)[C@@H]1CN2[C@H](CO1)CN(CC2)C(=O)OC(C)(C)C JVAIGDKSUPWSDC-BBRMVZONSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- DDGCQGHMZXCMLR-UHFFFAOYSA-N FC(C1=C(C=NN1)C=1C=C(C(=O)OCC)C=CC=1)(F)F Chemical compound FC(C1=C(C=NN1)C=1C=C(C(=O)OCC)C=CC=1)(F)F DDGCQGHMZXCMLR-UHFFFAOYSA-N 0.000 description 1
- CZKCXWADXDISQQ-WPRPVWTQSA-N FC(C1=CC=C([C@H]2OC[C@H](CNCC3)N3C2)N=N1)(F)F Chemical compound FC(C1=CC=C([C@H]2OC[C@H](CNCC3)N3C2)N=N1)(F)F CZKCXWADXDISQQ-WPRPVWTQSA-N 0.000 description 1
- LXWZBTGCXJZMBJ-NKUHCKNESA-N FC(C=CC(C1OC[C@H](CNCC2)N2C1)=C1)=C1Cl Chemical compound FC(C=CC(C1OC[C@H](CNCC2)N2C1)=C1)=C1Cl LXWZBTGCXJZMBJ-NKUHCKNESA-N 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000004547 Hallucinations Diseases 0.000 description 1
- 101000929834 Homo sapiens Monoacylglycerol lipase ABHD6 Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229910010082 LiAlH Inorganic materials 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- 102100035912 Monoacylglycerol lipase ABHD6 Human genes 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- VZEXJUAYWWLSEP-UHFFFAOYSA-N N.[Cl].Cl Chemical compound N.[Cl].Cl VZEXJUAYWWLSEP-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 208000001294 Nociceptive Pain Diseases 0.000 description 1
- IOTRMYQYBCADAR-UHFFFAOYSA-N O=C(C(C=CC=C1C2=CNN=C2F)=C1Cl)N(CC1)CC2N1CC(C(C=C1)=CC(Cl)=C1F)OC2 Chemical compound O=C(C(C=CC=C1C2=CNN=C2F)=C1Cl)N(CC1)CC2N1CC(C(C=C1)=CC(Cl)=C1F)OC2 IOTRMYQYBCADAR-UHFFFAOYSA-N 0.000 description 1
- FXNCBQLUFBFNDY-UHFFFAOYSA-N O=C(C(C=CC=C1C2=CNN=C2F)=C1Cl)N(CC1)CC2N1CC(C(C=C1)=NC=C1Br)OC2 Chemical compound O=C(C(C=CC=C1C2=CNN=C2F)=C1Cl)N(CC1)CC2N1CC(C(C=C1)=NC=C1Br)OC2 FXNCBQLUFBFNDY-UHFFFAOYSA-N 0.000 description 1
- SDAHDSQBMPBVBH-UHFFFAOYSA-N OC(=O)C1=CC=CC(OC(F)F)=C1Cl Chemical compound OC(=O)C1=CC=CC(OC(F)F)=C1Cl SDAHDSQBMPBVBH-UHFFFAOYSA-N 0.000 description 1
- VMNPEQJWXAQTPT-UHFFFAOYSA-N OC(=O)c1cc(F)cc(Br)c1Cl Chemical compound OC(=O)c1cc(F)cc(Br)c1Cl VMNPEQJWXAQTPT-UHFFFAOYSA-N 0.000 description 1
- WJDITLWAQAYDGM-DJJJIMSYSA-N O[C@]1(C2=CC=C(C(F)(F)F)N=C2)OC[C@H](CN(CC2)C(C(C=CC=C3Br)=C3Cl)=O)N2C1 Chemical compound O[C@]1(C2=CC=C(C(F)(F)F)N=C2)OC[C@H](CN(CC2)C(C(C=CC=C3Br)=C3Cl)=O)N2C1 WJDITLWAQAYDGM-DJJJIMSYSA-N 0.000 description 1
- VBUMMAWRCBSNFA-JQWIXIFHSA-N O[C@]1(C2=CC=C(C(F)(F)F)N=C2)OC[C@H](CNCC2)N2C1 Chemical compound O[C@]1(C2=CC=C(C(F)(F)F)N=C2)OC[C@H](CNCC2)N2C1 VBUMMAWRCBSNFA-JQWIXIFHSA-N 0.000 description 1
- WPSZUUVNLFBHPC-NYHFZMIOSA-N O[C@]1(C2=NC=C(C(F)(F)F)C=C2)OC[C@H](CN(CC2)C(C(C=CC=C3C4=CN=CO4)=C3Cl)=O)N2C1 Chemical compound O[C@]1(C2=NC=C(C(F)(F)F)C=C2)OC[C@H](CN(CC2)C(C(C=CC=C3C4=CN=CO4)=C3Cl)=O)N2C1 WPSZUUVNLFBHPC-NYHFZMIOSA-N 0.000 description 1
- JXWJSKCBTJUASY-JQWIXIFHSA-N O[C@]1(C2=NC=C(C(F)(F)F)C=C2)OC[C@H](CNCC2)N2C1 Chemical compound O[C@]1(C2=NC=C(C(F)(F)F)C=C2)OC[C@H](CNCC2)N2C1 JXWJSKCBTJUASY-JQWIXIFHSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010053395 Progressive multiple sclerosis Diseases 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 206010054094 Tumour necrosis Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- IOTRMYQYBCADAR-XOBRGWDASA-N [(3R,9aS)-3-(3-chloro-4-fluorophenyl)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-[2-chloro-3-(5-fluoro-1H-pyrazol-4-yl)phenyl]methanone Chemical compound C1CN(C[C@@H]2N1C[C@H](OC2)C3=CC(=C(C=C3)F)Cl)C(=O)C4=CC=CC(=C4Cl)C5=C(NN=C5)F IOTRMYQYBCADAR-XOBRGWDASA-N 0.000 description 1
- DCYSGVGYHZRMFU-QKKBWIMNSA-N [(3R,9aS)-3-hydroxy-3-[2-methyl-6-(trifluoromethyl)pyridin-3-yl]-1,4,6,7,9,9a-hexahydropyrazino[2,1-c][1,4]oxazin-8-yl]-(2-chloro-3-methoxyphenyl)methanone Chemical compound CC1=C(C=CC(=N1)C(F)(F)F)[C@@]2(CN3CCN(C[C@H]3CO2)C(=O)C4=C(C(=CC=C4)OC)Cl)O DCYSGVGYHZRMFU-QKKBWIMNSA-N 0.000 description 1
- MFSBQDPSMXDMEP-UHFFFAOYSA-N [2-chloro-3-(5-fluoro-1H-pyrazol-4-yl)phenyl]-[3-[6-(trifluoromethyl)pyridin-3-yl]-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]methanone Chemical compound C1CN(CC2N1CC(OC2)C3=CN=C(C=C3)C(F)(F)F)C(=O)C4=CC=CC(=C4Cl)C5=C(NN=C5)F MFSBQDPSMXDMEP-UHFFFAOYSA-N 0.000 description 1
- COERJHDMQUPDCV-UHFFFAOYSA-N [K].FB(F)F Chemical compound [K].FB(F)F COERJHDMQUPDCV-UHFFFAOYSA-N 0.000 description 1
- WJEIYVAPNMUNIU-UHFFFAOYSA-N [Na].OC(O)=O Chemical compound [Na].OC(O)=O WJEIYVAPNMUNIU-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000010976 amide bond formation reaction Methods 0.000 description 1
- 125000006242 amine protecting group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000002001 anti-metastasis Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- BFAKENXZKHGIGE-UHFFFAOYSA-N bis(2,3,5,6-tetrafluoro-4-iodophenyl)diazene Chemical compound FC1=C(C(=C(C(=C1F)I)F)F)N=NC1=C(C(=C(C(=C1F)F)I)F)F BFAKENXZKHGIGE-UHFFFAOYSA-N 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 208000025698 brain inflammatory disease Diseases 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- JMSRBKPMLUGHCR-UHFFFAOYSA-N bromohydrin Chemical compound BrC[C]1CO1 JMSRBKPMLUGHCR-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- AILAQOYFPLQIFN-UHFFFAOYSA-N butyl piperazine-1-carboxylate Chemical group CCCCOC(=O)N1CCNCC1 AILAQOYFPLQIFN-UHFFFAOYSA-N 0.000 description 1
- DOKPVDRODRRURS-UHFFFAOYSA-N butyl pyrazine-2-carboxylate Chemical group CCCCOC(=O)C1=CN=CC=N1 DOKPVDRODRRURS-UHFFFAOYSA-N 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229930003827 cannabinoid Natural products 0.000 description 1
- 239000003557 cannabinoid Substances 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- MOIPGXQKZSZOQX-UHFFFAOYSA-N carbonyl bromide Chemical compound BrC(Br)=O MOIPGXQKZSZOQX-UHFFFAOYSA-N 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- RSLSVURFMXHEEU-UHFFFAOYSA-M chloropalladium(1+);dicyclohexyl-[3-[2,4,6-tri(propan-2-yl)phenyl]phenyl]phosphane;2-phenylaniline Chemical compound [Pd+]Cl.NC1=CC=CC=C1C1=CC=CC=[C-]1.CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC(P(C2CCCCC2)C2CCCCC2)=C1 RSLSVURFMXHEEU-UHFFFAOYSA-M 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000037326 chronic stress Effects 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000004736 colon carcinogenesis Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000007257 deesterification reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 239000006274 endogenous ligand Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000006735 epoxidation reaction Methods 0.000 description 1
- 238000010931 ester hydrolysis Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 230000004136 fatty acid synthesis Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 description 1
- 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000003106 haloaryl group Chemical group 0.000 description 1
- 125000005216 haloheteroaryl group Chemical group 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 229940031993 lithium benzoate Drugs 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- LDJNSLOKTFFLSL-UHFFFAOYSA-M lithium;benzoate Chemical compound [Li+].[O-]C(=O)C1=CC=CC=C1 LDJNSLOKTFFLSL-UHFFFAOYSA-M 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000005394 methallyl group Chemical group 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- PSIMVWWDAVLHOI-UHFFFAOYSA-N methyl 2-chloro-3-(2-trimethylsilylethynyl)benzoate Chemical compound ClC1=C(C(=O)OC)C=CC=C1C#C[Si](C)(C)C PSIMVWWDAVLHOI-UHFFFAOYSA-N 0.000 description 1
- YHRRPKJFEXRRPK-UHFFFAOYSA-N methyl 2-chloro-3-(4-methylpyridin-3-yl)benzoate Chemical compound ClC1=C(C(=O)OC)C=CC=C1C=1C=NC=CC=1C YHRRPKJFEXRRPK-UHFFFAOYSA-N 0.000 description 1
- XUFDKATWIPPIJY-UHFFFAOYSA-N methyl 2-chloro-3-(5-phenylmethoxypyridazin-4-yl)benzoate Chemical compound C(C1=CC=CC=C1)OC=1C(=CN=NC=1)C=1C(=C(C(=O)OC)C=CC=1)Cl XUFDKATWIPPIJY-UHFFFAOYSA-N 0.000 description 1
- ZNJYMFPPZVOSHG-UHFFFAOYSA-N methyl 2-chloro-3-(6-methoxy-2-methylpyridin-3-yl)benzoate Chemical compound ClC1=C(C(=O)OC)C=CC=C1C=1C(=NC(=CC=1)OC)C ZNJYMFPPZVOSHG-UHFFFAOYSA-N 0.000 description 1
- CAJPQJSMUBYITI-UHFFFAOYSA-N methyl 2-chloro-3-ethynylbenzoate Chemical compound COC(C1=C(C(=CC=C1)C#C)Cl)=O CAJPQJSMUBYITI-UHFFFAOYSA-N 0.000 description 1
- LKZMOGYZLFRTQN-UHFFFAOYSA-N methyl 2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate Chemical compound COC(=O)C1=CC=CC(B2OC(C)(C)C(C)(C)O2)=C1F LKZMOGYZLFRTQN-UHFFFAOYSA-N 0.000 description 1
- VVFMGDHUTPSHBN-UHFFFAOYSA-N methyl 3-bromo-2-chloro-5-fluorobenzoate Chemical compound COC(=O)c1cc(F)cc(Br)c1Cl VVFMGDHUTPSHBN-UHFFFAOYSA-N 0.000 description 1
- YXZNVLYXBIIIOB-UHFFFAOYSA-N methyl 3-fluorobenzoate Chemical compound COC(=O)C1=CC=CC(F)=C1 YXZNVLYXBIIIOB-UHFFFAOYSA-N 0.000 description 1
- RLDJSZKPUPTTNO-UHFFFAOYSA-N methyl 5-bromo-1h-pyrazole-3-carboxylate Chemical compound COC(=O)C=1C=C(Br)NN=1 RLDJSZKPUPTTNO-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 125000004370 n-butenyl group Chemical group [H]\C([H])=C(/[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940097496 nasal spray Drugs 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000016273 neuron death Effects 0.000 description 1
- 230000004112 neuroprotection Effects 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 239000002581 neurotoxin Substances 0.000 description 1
- 231100000618 neurotoxin Toxicity 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000002825 nitriles Chemical group 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 150000002916 oxazoles Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004783 oxidative metabolism Effects 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 1
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 1
- UQPUONNXJVWHRM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 UQPUONNXJVWHRM-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- XNQULTQRGBXLIA-UHFFFAOYSA-O phosphonic anhydride Chemical compound O[P+](O)=O XNQULTQRGBXLIA-UHFFFAOYSA-O 0.000 description 1
- 125000005499 phosphonyl group Chemical group 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000002600 positron emission tomography Methods 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 description 1
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- BQMPGKPTOHKYHS-UHFFFAOYSA-N pyrrole-2-carbonitrile Natural products N#CC1=CC=CN1 BQMPGKPTOHKYHS-UHFFFAOYSA-N 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 1
- 230000003238 somatosensory effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- VNFWTIYUKDMAOP-UHFFFAOYSA-N sphos Chemical compound COC1=CC=CC(OC)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 VNFWTIYUKDMAOP-UHFFFAOYSA-N 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- BCPPNDHZUPIXJM-QMMMGPOBSA-N tert-butyl (2s)-2-(hydroxymethyl)piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNC[C@H]1CO BCPPNDHZUPIXJM-QMMMGPOBSA-N 0.000 description 1
- ZQDNMALGBQYSNR-LDCVWXEPSA-N tert-butyl (3r)-4-[2-(3-cyano-4-fluorophenyl)-2-hydroxyethyl]-3-(hydroxymethyl)piperazine-1-carboxylate Chemical compound OC[C@H]1CN(C(=O)OC(C)(C)C)CCN1CC(O)C1=CC=C(F)C(C#N)=C1 ZQDNMALGBQYSNR-LDCVWXEPSA-N 0.000 description 1
- VCZIHLHJIRMBJB-LDCVWXEPSA-N tert-butyl (9ar)-3-(3-cyano-4-fluorophenyl)-3,4,6,7,9,9a-hexahydro-1h-pyrazino[2,1-c][1,4]oxazine-8-carboxylate Chemical compound C([C@@H]1CO2)N(C(=O)OC(C)(C)C)CCN1CC2C1=CC=C(F)C(C#N)=C1 VCZIHLHJIRMBJB-LDCVWXEPSA-N 0.000 description 1
- BCPPNDHZUPIXJM-UHFFFAOYSA-N tert-butyl 2-(hydroxymethyl)piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1CO BCPPNDHZUPIXJM-UHFFFAOYSA-N 0.000 description 1
- JDIARRKHPCVARB-UHFFFAOYSA-N tert-butyl 3-(hydroxymethyl)-3-methylpiperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNC(C)(CO)C1 JDIARRKHPCVARB-UHFFFAOYSA-N 0.000 description 1
- ORFDPTULTZCDBZ-UHFFFAOYSA-N tert-butyl 4-[2-(3-chloro-4-fluorophenyl)-2-hydroxyethyl]-3-(hydroxymethyl)-3-methylpiperazine-1-carboxylate Chemical compound ClC=1C=C(C=CC=1F)C(CN1C(CN(CC1)C(=O)OC(C)(C)C)(C)CO)O ORFDPTULTZCDBZ-UHFFFAOYSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 1
- USFPINLPPFWTJW-UHFFFAOYSA-N tetraphenylphosphonium Chemical compound C1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 USFPINLPPFWTJW-UHFFFAOYSA-N 0.000 description 1
- 125000004495 thiazol-4-yl group Chemical group S1C=NC(=C1)* 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- YZCLFYPXHSRNHI-UHFFFAOYSA-N tributyl(methylidene)-$l^{5}-phosphane Chemical compound CCCCP(=C)(CCCC)CCCC YZCLFYPXHSRNHI-UHFFFAOYSA-N 0.000 description 1
- PBIMIGNDTBRRPI-UHFFFAOYSA-N trifluoro borate Chemical compound FOB(OF)OF PBIMIGNDTBRRPI-UHFFFAOYSA-N 0.000 description 1
- WUUHFRRPHJEEKV-UHFFFAOYSA-N tripotassium borate Chemical compound [K+].[K+].[K+].[O-]B([O-])[O-] WUUHFRRPHJEEKV-UHFFFAOYSA-N 0.000 description 1
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- 229910052722 tritium Inorganic materials 0.000 description 1
- 230000005748 tumor development Effects 0.000 description 1
- 230000004222 uncontrolled growth Effects 0.000 description 1
- 238000006886 vinylation reaction Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- GTLDTDOJJJZVBW-UHFFFAOYSA-N zinc cyanide Chemical compound [Zn+2].N#[C-].N#[C-] GTLDTDOJJJZVBW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19185088.2 | 2019-07-09 | ||
| EP19185088 | 2019-07-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202116781A true TW202116781A (zh) | 2021-05-01 |
Family
ID=67220669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW109123050A TW202116781A (zh) | 2019-07-09 | 2020-07-08 | 新穎雜環化合物 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20220242876A1 (https=) |
| EP (1) | EP3997096B1 (https=) |
| JP (1) | JP7649283B2 (https=) |
| KR (1) | KR20220034104A (https=) |
| CN (1) | CN114096545A (https=) |
| AR (1) | AR119376A1 (https=) |
| AU (1) | AU2020311584A1 (https=) |
| BR (1) | BR112021026899A2 (https=) |
| CA (1) | CA3145338A1 (https=) |
| CL (1) | CL2022000019A1 (https=) |
| CO (1) | CO2022000186A2 (https=) |
| CR (1) | CR20220004A (https=) |
| IL (1) | IL288987A (https=) |
| MX (1) | MX2022000243A (https=) |
| PE (1) | PE20220515A1 (https=) |
| PH (1) | PH12021553249A1 (https=) |
| TW (1) | TW202116781A (https=) |
| WO (1) | WO2021005034A1 (https=) |
| ZA (1) | ZA202110352B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019134985A1 (en) | 2018-01-08 | 2019-07-11 | F. Hoffmann-La Roche Ag | Octahydropyrido[1,2-alpha]pyrazines as magl inhibitors |
| PE20211089A1 (es) | 2018-08-13 | 2021-06-14 | Hoffmann La Roche | Nuevos compuestos heterociclicos como inhibidores de la monoacilglicerol lipasa |
| WO2020104494A1 (en) | 2018-11-22 | 2020-05-28 | F. Hoffmann-La Roche Ag | New heterocyclic compounds |
| CN114269755A (zh) | 2019-09-12 | 2022-04-01 | 豪夫迈·罗氏有限公司 | 作为magl抑制剂的4,4a,5,7,8,8a-六吡啶并[4,3-b][1,4]噁嗪-3-酮化合物 |
| CA3190277A1 (en) | 2020-09-03 | 2022-03-10 | Joerg Benz | Heterocyclic compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2014001946A (es) * | 2011-08-19 | 2014-03-27 | Merck Sharp & Dohme | Inhibidores del canal de potasio medularmente externo renal. |
| US9573961B2 (en) | 2012-12-19 | 2017-02-21 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| WO2017087863A1 (en) * | 2015-11-20 | 2017-05-26 | Abide Therapeutics, Inc. | Pyrazole compounds and methods of making and using same |
| EP3571202B1 (en) * | 2017-01-23 | 2021-06-30 | Pfizer Inc. | Heterocyclic spiro compounds as magl inhibitors |
| JOP20190267A1 (ar) * | 2017-05-23 | 2019-11-18 | Lundbeck La Jolla Research Center Inc | مثبطات بيرازول magl |
| JP7257387B2 (ja) * | 2017-08-29 | 2023-04-13 | ハー・ルンドベック・アクチエゼルスカベット | スピロ環化合物並びにその作製及び使用方法 |
| WO2019134985A1 (en) * | 2018-01-08 | 2019-07-11 | F. Hoffmann-La Roche Ag | Octahydropyrido[1,2-alpha]pyrazines as magl inhibitors |
| MX2022000083A (es) * | 2019-07-03 | 2022-02-03 | Hoffmann La Roche | Inhibidores de monoacilglicerol lipasa (magl) heterociclicos. |
-
2020
- 2020-07-07 CN CN202080050165.3A patent/CN114096545A/zh active Pending
- 2020-07-07 AU AU2020311584A patent/AU2020311584A1/en not_active Abandoned
- 2020-07-07 CR CR20220004A patent/CR20220004A/es unknown
- 2020-07-07 PH PH1/2021/553249A patent/PH12021553249A1/en unknown
- 2020-07-07 JP JP2022500908A patent/JP7649283B2/ja active Active
- 2020-07-07 CA CA3145338A patent/CA3145338A1/en active Pending
- 2020-07-07 BR BR112021026899A patent/BR112021026899A2/pt not_active Application Discontinuation
- 2020-07-07 MX MX2022000243A patent/MX2022000243A/es unknown
- 2020-07-07 EP EP20740259.5A patent/EP3997096B1/en active Active
- 2020-07-07 WO PCT/EP2020/069074 patent/WO2021005034A1/en not_active Ceased
- 2020-07-07 KR KR1020227000611A patent/KR20220034104A/ko not_active Ceased
- 2020-07-07 PE PE2021002265A patent/PE20220515A1/es unknown
- 2020-07-08 TW TW109123050A patent/TW202116781A/zh unknown
- 2020-07-08 AR ARP200101928A patent/AR119376A1/es not_active Application Discontinuation
-
2021
- 2021-12-13 ZA ZA2021/10352A patent/ZA202110352B/en unknown
- 2021-12-14 IL IL288987A patent/IL288987A/en unknown
-
2022
- 2022-01-04 CL CL2022000019A patent/CL2022000019A1/es unknown
- 2022-01-06 US US17/569,749 patent/US20220242876A1/en active Pending
- 2022-01-13 CO CONC2022/0000186A patent/CO2022000186A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH12021553249A1 (en) | 2023-02-27 |
| BR112021026899A2 (pt) | 2022-05-10 |
| EP3997096A1 (en) | 2022-05-18 |
| ZA202110352B (en) | 2022-08-31 |
| CR20220004A (es) | 2022-01-31 |
| WO2021005034A1 (en) | 2021-01-14 |
| EP3997096C0 (en) | 2024-08-28 |
| CL2022000019A1 (es) | 2022-10-21 |
| IL288987A (en) | 2022-02-01 |
| CO2022000186A2 (es) | 2022-01-17 |
| PE20220515A1 (es) | 2022-04-07 |
| AR119376A1 (es) | 2021-12-15 |
| JP7649283B2 (ja) | 2025-03-19 |
| EP3997096B1 (en) | 2024-08-28 |
| KR20220034104A (ko) | 2022-03-17 |
| MX2022000243A (es) | 2022-02-03 |
| JP2022539604A (ja) | 2022-09-12 |
| US20220242876A1 (en) | 2022-08-04 |
| AU2020311584A1 (en) | 2022-01-20 |
| CA3145338A1 (en) | 2021-01-14 |
| CN114096545A (zh) | 2022-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7609854B2 (ja) | Magl阻害剤としての4,4a,5,7,8,8a-ヘキサピリド[4,3-b][1,4]オキサジン-3-オン化合物 | |
| TWI818967B (zh) | 新穎雜環化合物 | |
| TWI812770B (zh) | 新穎雜環化合物 | |
| JP7649283B2 (ja) | 新規複素環化合物 | |
| US11242334B2 (en) | Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof | |
| JP2021533093A (ja) | モノアシルグリセロールリパーゼ阻害剤としての新規複素環化合物 | |
| JP2022527590A (ja) | モノアシルグリセロールリパーゼ(magl)の阻害剤としての複素環式化合物 | |
| JP7669299B2 (ja) | 複素環モノアシルグリセロールリパーゼ(magl)阻害剤 | |
| CA2935071A1 (en) | Piperidine-dione derivatives | |
| CN114401968A (zh) | 新颖杂环单酰基甘油脂肪酶(magl)抑制剂 | |
| TW201625625A (zh) | 做為pde2抑制劑之經取代的[1,2,4]三唑并[1,5-a]嘧啶-7-基化合物 | |
| US20260015360A1 (en) | Biaryl derivatives and related uses | |
| TW202333664A (zh) | 新穎雜環化合物 | |
| HK40068386A (en) | New heterocyclic compounds | |
| HK40065118A (en) | New heterocyclic monoacylglycerol lipase (magl) inhibitors | |
| HK40062310A (en) | 4,4a,5,7,8,8a-hexapyrido[4,3-b][1,4]oxazin-3-one compounds as magl inhibitors | |
| HK40035599A (en) | Oxazine monoacylglycerol lipase (magl) inhibitors |